Community - Public Portfolios & Trending Stocks | AllInvestView

Earnings Recaps

Browse reported earnings of the most popular stocks

Aug 14, 2026 Aug 13, 2026 Aug 12, 2026 Aug 11, 2026 Aug 10, 2026 Aug 9, 2026 Aug 8, 2026 Aug 7, 2026 Aug 6, 2026 Aug 5, 2026 Aug 4, 2026 Aug 3, 2026 Aug 2, 2026 Aug 1, 2026 Jul 31, 2026 Jul 30, 2026 Jul 29, 2026 Jul 28, 2026 Jul 27, 2026 Jul 26, 2026 Jul 25, 2026 Jul 24, 2026 Jul 23, 2026 Jul 22, 2026 Jul 21, 2026 Jul 20, 2026 Jul 19, 2026 Jul 18, 2026 Jul 17, 2026 Jul 16, 2026 Jul 12, 2026 Jul 11, 2026 Jul 10, 2026 Jul 9, 2026 Jul 3, 2026 Jul 2, 2026 Jul 1, 2026 Jun 30, 2026 Jun 28, 2026 Jun 27, 2026 Jun 26, 2026 Jun 25, 2026 Jun 24, 2026 Jun 20, 2026 Jun 19, 2026 Jun 18, 2026 Jun 17, 2026 Jun 15, 2026 Jun 14, 2026 Jun 13, 2026 Jun 12, 2026 Jun 11, 2026 Jun 10, 2026 Jun 9, 2026 Jun 6, 2026 Jun 5, 2026 Jun 4, 2026 Jun 3, 2026 Jun 2, 2026 Jun 1, 2026 May 31, 2026 May 30, 2026 May 29, 2026 May 28, 2026 May 27, 2026 May 26, 2026 May 24, 2026 May 23, 2026 May 22, 2026 May 21, 2026 May 20, 2026 May 19, 2026 May 18, 2026 May 17, 2026 May 16, 2026 May 15, 2026 May 14, 2026 May 13, 2026 May 12, 2026 May 11, 2026 May 10, 2026 May 9, 2026 May 8, 2026 May 7, 2026 May 6, 2026 May 5, 2026 May 4, 2026 May 3, 2026 May 2, 2026 May 1, 2026 Apr 30, 2026 Apr 29, 2026 Apr 23, 2026 Apr 22, 2026 Apr 21, 2026 Apr 20, 2026 Apr 18, 2026 Apr 17, 2026 Apr 16, 2026 Apr 15, 2026 Apr 14, 2026 Apr 13, 2026 Apr 10, 2026 Apr 9, 2026 Apr 8, 2026 Apr 7, 2026 Apr 2, 2026 Apr 1, 2026 Mar 31, 2026 Mar 30, 2026 Mar 26, 2026 Mar 25, 2026 Mar 20, 2026 Mar 19, 2026 Mar 18, 2026 Mar 17, 2026 Mar 16, 2026 Mar 13, 2026 Mar 12, 2026 Mar 11, 2026 Mar 9, 2026 Mar 7, 2026 Mar 6, 2026 Mar 5, 2026 Mar 4, 2026 Mar 3, 2026 Mar 2, 2026 Feb 28, 2026 Feb 27, 2026 Feb 26, 2026 Feb 25, 2026 Feb 24, 2026 Feb 23, 2026 Feb 21, 2026 Feb 20, 2026 Feb 19, 2026 Feb 18, 2026 Feb 17, 2026 Feb 14, 2026 Feb 13, 2026 Feb 12, 2026 Feb 11, 2026 Feb 10, 2026 Feb 9, 2026 Feb 7, 2026 Feb 6, 2026 Feb 5, 2026 Feb 4, 2026 Feb 3, 2026 Feb 2, 2026 Jan 31, 2026 Jan 30, 2026 Jan 29, 2026 Jan 28, 2026 Jan 27, 2026 Jan 26, 2026 Jan 23, 2026 Jan 22, 2026 Jan 21, 2026 Jan 20, 2026 Jan 17, 2026 Jan 16, 2026 Jan 15, 2026 Jan 14, 2026 Jan 9, 2026 Jan 8, 2026 Jan 7, 2026 Jan 6, 2026 Dec 19, 2025 Dec 18, 2025 Dec 17, 2025 Dec 12, 2025 Dec 11, 2025 Dec 10, 2025 Dec 9, 2025 Dec 6, 2025 Dec 5, 2025 Dec 4, 2025 Dec 3, 2025

143 companies Today

AbCellera Biologics Inc.

ABCL Q2 2026

Reported: 2026-08-07

AbCellera's stock rose 7.2% after announcing sizable upfront payments from its new T cell engager (TCE) collaborations with Vertex and Jazz Pharmaceuticals, which added over $110 million in near-term cash and significant potential downstream revenue.

Key takeaways

Completed enrollment and initial dosing for the Phase II study of ABCL635 in menopause-related hot flashes, with data expected imminently.
Advanced pipeline programs ABCL-688 and ABCL386 are expected to enter Phase I/II trials in 2027; ABCL575 Phase I dosing completed with readout due in Q4.
Missed prior goal to move a program into IND-enabling activities in H1 but reported ongoing progress in discovery.
Announced two new TCE collaborations: $28 million upfront from Vertex targeting autoimmune diseases, and $84 million upfront (with $56 million received) from Jazz, with potential total deal values exceeding $4 billion across five programs.
Strong liquidity position with $565 million cash and equivalents plus $110 million of committed government funding to support strategic execution.

Aurora Cannabis Inc.

ACB Q1 2027

Reported: 2026-08-07

Shares rose 6% on stronger-than-expected international medical cannabis revenue growth and solid margin expansion, driven by leadership in Germany and the accretive acquisition of EU GMP-certified manufacturing capacity.

Key takeaways

International medical cannabis net revenue increased 17% to $43 million, representing 64% of total net revenue, up from 50% a year ago.
Adjusted gross margin reached 58%, at the high end of the expected annual range, supported by strong contributions from international markets.
Acquisition of Safari Flower Company, with its EU GMP-certified 59,000 square foot facility, added critical manufacturing capacity and was accretive to adjusted EBITDA.
Germany remains the largest and fastest-growing market, with Aurora maintaining premium and core segment leadership despite pricing pressure and increased competition.
The company ended the quarter with nearly $150 million in cash, no debt, and ongoing investments to expand EU GMP production capacity and improve yields through plant science.

Archer-Daniels-Midland Company

ADM Q2 2026

Reported: 2026-08-07

ADM’s shares edged down 0.6% following its Q2 report as the market appeared cautious despite generally stable execution and rising guidance, signaling skepticism over the sustainability of margin gains and the pace of growth ahead.

Key takeaways

Reported adjusted EPS of $1.84 and segment operating profit of $1.5 billion for Q2 2026.
Raised full-year adjusted EPS guidance significantly to $5.15–$5.60 from $4.15–$4.70, citing strong first-half results and a positive outlook.
Global oilseed processing volumes increased by nearly 5% year-over-year, supported by higher asset utilization.
Biofuels benefited from robust margins amid elevated energy prices and favorable ethanol export conditions.
Nutrition segment showed momentum with growth in Flavors and Animal Nutrition, supported by portfolio actions and regional strength.

Aeva Technologies, Inc.

AEVA Q2 2026

Reported: 2026-08-07

Shares rose 23.6% following better-than-expected commercial momentum highlighted by significant progress in both automotive programs and a major new optical connectivity market expansion, signaling strong investor confidence in Aeva’s growth prospects and technology validation.

Key takeaways

Announced entry into the AI data center market with optical connectivity solutions leveraging existing silicon photonics technology, including a key joint development agreement targeting initial volumes in 2027 and ramping in 2028.
Optical connectivity deal with a leading high-speed optical engine provider for a major hyperscaler has potential to generate multiple hundreds of millions in annual revenue and scale to millions of units.
Automotive segment continues scaling with production-intent Atlas sensors for Daimler Truck and automated manufacturing line at Jabil North America operational, enabling production ramp-up.
Progress on passenger vehicle programs includes delivery of Atlas Ultra systems and collaboration with a top 10 European OEM and NVIDIA for next-generation ADAS platforms.
Strengthened balance sheet with over $300 million liquidity post follow-on equity offering to support commercial deployment and supply chain scaling.

Alight, Inc.

ALIT Q2 2026

Reported: 2026-08-07

Shares fell 26.5% following the quarter as investors reacted to ongoing revenue deceleration and cautious near-term outlook driven by a persistent recurring revenue decline and reliance on unpredictable project revenue.

Key takeaways

Revenue totaled $511 million, with recurring revenue down 4.3% year-over-year due to prior commercial challenges and a 12-18 month lag in revenue realization.
Project revenue rose approximately 11% year-over-year, but remains volatile and a key source of quarter-to-quarter fluctuations.
EBITDA margin was 18%, supported by higher-than-expected revenue, but margin pressure remains a risk given revenue dynamics.
Free cash flow of $48 million in the quarter, totaling $101 million year-to-date, reflects solid liquidity with $215 million cash on hand and a $330 million undrawn revolver.
Management highlighted ongoing investments in technology and client service insourcing, but the transformation is insufficient to offset near-term revenue headwinds.

The Allstate Corporation

ALL Q2 2026

Reported: 2026-08-07

Shares rose 4.8% as Allstate delivered better-than-expected revenue growth driven by strong premium increases and significant investment income gains that bolstered earnings. The operational discipline and transformative growth initiatives underpinning margin improvement further supported investor confidence.

Key takeaways

Total revenues climbed 11.8% year-over-year to $18.6 billion, reflecting a 2.6% increase in net premiums written supported by growth in auto and homeowners insurance.
Policies in force expanded 3.8% to 215.9 million, driven by 2.6% growth in Property-Liability and 4.1% in Protection Services.
Net investment income surged 33.8% to $1 billion, benefiting from a larger portfolio, longer duration, and increased performance-based gains.
The Property-Liability combined ratio improved 4.5 points to 86.6%, with the underlying combined ratio flat at 79.4%, highlighting maintained underwriting discipline.
Adjusted net income reached $2.3 billion, or $8.99 per share, with a 44.2% adjusted net income return on equity over 12 months, signaling high profitability.

Alto Ingredients, Inc.

ALTO Q2 2026

Reported: 2026-08-07

Alto Ingredients’ shares declined 14.7% following earnings as the market reacted negatively to a cautious outlook and challenges in export volumes despite strong domestic ethanol margins and operational improvements.

Key takeaways

Q2 crush margins improved to $0.33 per gallon from $0.11 year-over-year, driven by strong domestic demand, export demand, and favorable corn costs.
Export volumes fell due to geopolitical disruptions in the Middle East, higher freight costs, and increased competition from Brazilian ethanol in Europe.
Operational investments included an 8% capacity increase at the Pekin dry mill, expected to fully benefit by Q4, plus ongoing infrastructure upgrades at ICP and Columbia facilities.
Company remains focused on increasing 45Z tax credits, targeting at least $15 million in income from these credits in 2026.
Despite positive margin trends and capacity expansions, the uncertain export outlook and cautious commentary on geopolitical risks weighed heavily on investor sentiment.

Amprius Technologies, Inc.

AMPX Q2 2026

Reported: 2026-08-07

Amprius shares rose 3.5% following a second-quarter beat driven by strong demand and new customer wins in its silicon anode battery business, notably in military and commercial drones. Market confidence was bolstered by an increased 2026 revenue forecast and expanding contract backlog.

Key takeaways

Record Q2 revenue fueled by accelerating adoption of the second-generation SiCore silicon anode battery in drones and other applications.
Raised 2026 revenue guidance for the second consecutive quarter, reflecting sustained market momentum.
Defense segment growth supported by a $24 million order from a new European drone manufacturer and a $18.1 million contract extension with the Defense Innovation Unit.
Signed a new multi-year contract with Stark Future for electric mobility products, expanding beyond drones into light electric vehicles in China.
Pilot line equipment installation progressing on schedule, with production targeted for December 2026 to scale manufacturing capacity.

ams AG

AMS.SW Q2 2026

Reported: 2026-08-07

The market reacted positively to a 11.4% stock increase, reflecting investor approval of accelerated growth in the semiconductor core business and significant progress in scaling the Digital Photonics segment.

Key takeaways

Semiconductor core grew 13% year-over-year on a like-for-like basis, driven by strength in automotive and industrial demand, nearly doubling the midterm growth model’s implied rate.
Digital Photonics advanced toward commercialization with key milestones in microLED and AI photonics, alongside strategic hires and organizational restructuring.
Revenues reached EUR 805 million, landing in the upper half of guidance; adjusted EBITDA margin was near 17%, at the high end of guidance range.
Segment-wise, operating system division saw 11% sequential revenue growth but faced margin pressure from rising gold prices (+25%) and FX headwinds.
Automotive LED business grew 5% YoY with ongoing share gains, while industrial/medical segment showed robust sequential growth (~30%), offsetting softness in China consumer demand.

ams AG

AMSSY Q2 2026

Reported: 2026-08-07

The shares jumped 11.4% post-earnings, driven by semiconductor core growth and solid progress in Digital Photonics, which together reinforced confidence in the company’s long-term growth despite margin pressures and FX headwinds.

Key takeaways

Semiconductor core business grew 13% year-on-year on a like-for-like basis, nearly double the midterm model’s implied growth, supported by automotive strength and industrial demand recovery.
Digital Photonics advanced notably with key milestones in microLED arrays and AI photonics, signaling a shift from development to commercial scale.
Revenue reached EUR 805 million, up 4% year-on-year and 9% like-for-like, landing at the high end of guidance.
Adjusted EBITDA margin near 17%, at the top of the guidance range, despite heavier raw material costs (notably a 25%+ increase in gold prices) and FX headwinds that weighed on profitability.
The divestment of non-core businesses, including specialty lamps and subscale CMOS image sensors, sharpened strategic focus and improved the balance sheet with EUR 1 billion senior notes reducing annual interest expense by EUR 40 million.

AppLovin Corporation

APP Q2 2026

Reported: 2026-08-07

AppLovin's stock dropped 20% after the company fell short of guidance due to a timing-related deceleration in model performance, which limited advertiser spend growth and contributed to adjusted EBITDA missing expectations despite strong consumer segment growth.

Key takeaways

Revenue reached $1.92 billion, up 53% year-over-year but slightly below the midpoint of guided range.
Adjusted EBITDA was $1.61 billion, up 58% year-over-year but just below guidance, pressured by increased compute costs for model training.
Gaming revenue growth slowed due to lighter-than-usual model performance improvements during the quarter, delaying the expected uplift to early Q3.
Consumer segment delivered strong performance with advertiser spend rising 28% above Q4 2025 levels, signaling steep growth but still too small to offset gaming deceleration fully.
Free cash flow totaled $863 million, with below-normal conversion attributed to the timing of international tax and interest payments, expected to normalize in Q3.

Array Technologies, Inc.

ARRY Q2 2026

Reported: 2026-08-07

Shares dropped 12.6% following the earnings release as investors reacted to signs of margin pressure and a cautious outlook despite strong revenue growth. The market appears concerned about slowing momentum in key segments and the implications for profitability ahead.

Key takeaways

Revenue surged 53% sequentially to $342 million, driven by 38% growth in tracker volumes and increased activity in the APA business.
Adjusted gross margin held at 30.8%, but margin compression concerns linger due to integration costs and scaling challenges.
Adjusted EBITDA doubled sequentially to $63 million, with margins improving over 18%, yet the market’s reaction suggests skepticism about sustained margin expansion.
Order backlog hit a record $2.5 billion, up 37% year-over-year, with a strong book-to-bill ratio of 1.5x signaling solid demand.
APA acquisition integration progressing, expanding addressable markets and product offerings, but incremental margin contribution remains uncertain.

Amtech Systems, Inc.

ASYS Q3 2026

Reported: 2026-08-07

Amtech Systems shares dropped 14.3% after the quarter as investor optimism on AI-driven growth was overshadowed by a disappointing revenue decline and ongoing structural challenges in its Semiconductor Fabrication Solutions segment.

Key takeaways

Total revenue rose 14% year-over-year to $22.4 million, hitting the high end of guidance, primarily driven by a 120% surge in AI-related demand within the Thermal Processing Solutions segment.
Thermal Processing Solutions segment revenue grew nearly 25%, supported by strong AI equipment sales and a book-to-bill ratio near 1.4, indicating robust order momentum.
Semiconductor Fabrication Solutions segment saw a significant revenue decline due to a sustained drop in demand for PR Hoffman templates in silicon carbide substrate manufacturing, with no expected recovery.
Gross margin improved to 50%, and adjusted EBITDA reached $3.3 million (approximately 15% of sales), aided by operating leverage from a semi-fabless model.
Cash position strengthened to $83.1 million, boosted by a $56.5 million net raise from a recent oversubscribed stock offering.

BROOKFIELD ASSET MANAGEMENT INC

BAM Q2 2026

Reported: 2026-08-07

The modest 2.4% stock rise suggests investors viewed Brookfield Asset Management’s Q2 results as broadly in line with expectations, reflecting solid fundraising and earnings growth but no clear upside surprise or signs of margin expansion to drive a stronger rally.

Key takeaways

Fee-related earnings rose 20% year-over-year to $808 million, underpinning steady growth across the platform.
Distributable earnings increased 15% to $707 million, demonstrating consistent cash generation.
Fee-bearing capital grew 19% over twelve months, reaching $672 billion, highlighting asset base expansion.
Record quarterly fundraising totaled $77 billion, led by the $40 billion Just Group mandate, boosting insurance-related fee revenue without insurance liabilities.
Brookfield emphasized leading positions in real assets, credit (post-Oaktree acquisition), and AI infrastructure, supported by expanded partnerships, yet the market response suggests no meaningful acceleration in margins or guidance.

Brookfield Asset Management Ltd.

BAM.TO Q2 2026

Reported: 2026-08-07

Brookfield Asset Management's shares rose modestly by 1.8% following the quarter, reflecting solid fundraising and growth in fee-bearing capital and earnings, but without a strong near-term catalyst to drive a bigger market reaction.

Key takeaways

Fee-related earnings rose 20% year-over-year to $808 million; distributable earnings increased 15% to $707 million.
Fee-bearing capital grew 19% over the past 12 months, reaching $672 billion.
Record fundraising of $77 billion in the quarter, led primarily by the $40 billion Just Group mandate.
Strategic AI infrastructure initiatives expanded, including scaling partnerships with Bloom Energy and sovereign governments, positioning Brookfield in a high-growth segment.
Integration of Oaktree complete, enhancing credit platform scale and capabilities for across-cycle performance.

The Liberty Braves Group

BATRA Q2 2026

Reported: 2026-08-07

Shares dropped 4.0% as investors reacted negatively to signs of deceleration in the media segment, driven by ongoing declines in traditional cable subscriptions that pressured broadcasting revenue despite growth in the new BravesVision platform.

Key takeaways

BravesVision launch shifted the broadcasting revenue line to media-related revenue, reflecting mixed impacts from operating the platform directly.
Traditional cable subscriber declines accelerated, exerting pressure on media revenue and offsetting early gains from direct-to-consumer growth.
Direct-to-consumer revenue is growing faster than initial projections but has not fully compensated for losses in legacy distribution.
On-field performance remained solid with strong playoff probability and key players returning from injury, supporting franchise competitiveness.
Management emphasized long-term potential of BravesVision but acknowledged challenges in transitioning from third-party rights to a direct model.

Bayer Aktiengesellschaft

BAYN.DE Q2 2026

Reported: 2026-08-07

The market reacted positively with a 4.5% gain, reflecting better-than-expected margin expansion in Crop Science and solid growth in key Pharma franchises, offsetting legacy litigation costs and flat overall sales.

Key takeaways

Crop Science sales grew 5.5%, driven by seeds, traits, and licensing revenue; EBITDA margin expanded to 31%, a notable improvement over prior year.
Pharma sales were flat overall but benefited from 66% combined growth in Nubeqa and Kerendia, partially mitigating declines in Xarelto and a 27% drop in Eylea due to biosimilar pressure. EBITDA margin was steady at 26%.
Consumer Health grew 3.5% with broad contributions, though EBITDA margin trailed last year but remains on track for guidance.
Free cash flow was negative EUR 2.7 billion, worsening from last year due to litigation-related payouts, underscoring ongoing financial overhangs.
The Supreme Court ruling on Monsanto litigation provided regulatory clarity, strengthening Bayer’s legal position, supporting investor confidence.

Bed Bath & Beyond Inc.

BBBY Q2 2026

Reported: 2026-08-07

Shares plunged 13.2% following earnings as investors reacted negatively to a cautious outlook and the absence of clear margin expansion despite modest top-line growth, signaling ongoing operational challenges and integration costs weighing on profitability.

Key takeaways

Omnichannel revenue rose 28% year-over-year, driven by both marketplace and physical store sales.
Base e-commerce business showed growth for the second consecutive quarter after prolonged declines.
Orders doubled, contributing to improved gross margin on a reported basis.
Merger and transaction-related costs continued to pressure operating margins.
Management emphasized a long-term transformation strategy but provided limited near-term margin guidance, leading to investor caution.

BioCryst Pharmaceuticals, Inc.

BCRX Q2 2026

Reported: 2026-08-07

BioCryst’s shares gained 3.1% following Q2 results highlighted by solid ORLADEYO revenue growth and successful pediatric launch execution, reflecting confidence in commercial momentum and operational progress.

Key takeaways

Total revenue rose 45% year-over-year on a comparable basis, excluding the European divestiture.
ORLADEYO revenue increased 10% year-over-year to $158.2 million, supported by strong new patient demand and steady new prescriber additions.
Pediatric ORLADEYO pellets launched with 47 prescriptions received through July 31, exceeding full-year expectations despite earlier manufacturing delays.
Paid prescription rate improved slightly to 84%, up from 83% a year ago, following completion of a major reauthorization season.
Strategic shift to end internal drug discovery to focus on external innovation aims to build a more balanced pipeline without impacting current clinical programs.

Booking Holdings Inc.

BKNG Q2 2026

Reported: 2026-08-07

Booking Holdings' shares rose 7.4% as the company demonstrated resilience amid macro uncertainties, driven by better-than-expected execution, sustained transaction growth across multiple travel verticals, and strategic progress in key markets.

Key takeaways

Transaction growth was fueled by connected trip bookings, which grew in the low double digits and now constitute a low double-digit percentage of total Booking.com transactions, outpacing overall growth rates.
The Genius loyalty program continued to expand, with Level 2 and 3 members making up over 30% of the active customer base and accounting for a high 50% share of room nights, both increases year-over-year.
U.S. unit room nights grew in the high single digits, supported by strong domestic demand and improvements in direct booking channels.
Asia showed healthy underlying domestic demand despite competitive pressures and geopolitical headwinds, supported by localized product and payment investments.
Structural cost savings from the ongoing transformation program are enabling increased investment in innovation and strategic priorities, including AI integration efforts to enhance the traveler experience.

Blue Bird Corporation

BLBD Q3 2026

Reported: 2026-08-07

Blue Bird’s stock fell sharply by 15.2% following an earnings report that disappointed investors primarily due to a cautious outlook and increased uncertainty around tariff volatility and strategic expansion costs, despite solid underlying operational execution.

Key takeaways

Reported Q3 revenue rose to $517 million, up $119 million year-over-year, driven by the sale of 3,525 buses.
Adjusted EBITDA improved to $71 million, a $13 million increase from last year, and adjusted free cash flow totaled $28 million.
Alt-Power segment continued strong with 54% unit sales mix; EV bookings stood at 355 units with 776 units in backlog heading into 2027.
The backlog finished at 4,900 units, supported by order intake growth of 9% over 12 months, indicating stable demand despite market headwinds.
Investors reacted negatively amidst concerns about the margin-neutral tariff recovery strategy, uncertainty in future funding for the EPA Clean School Bus program, and the sizable investment and integration risk from the new chassis market entry and Detroit Chassis asset purchase.

Bumble Inc.

BMBL Q2 2026

Reported: 2026-08-07

Bumble shares fell sharply by 11.1% after earnings, largely due to setbacks in the technology platform migration that delayed key product innovations and pushed out the rollout of new interaction features into early 2027, undermining growth momentum and investor confidence.

Key takeaways

Migration of critical data to a new cloud platform is delayed by several months due to complexity, slowing the launch of reimagined app features.
Product innovation cadence is impaired; management cites frustration over inability to ship highly demanded features at a competitive pace.
Early tests of new chat initiation and interaction improvements show positive member engagement lift but are limited in rollout scope.
Growth initiatives focused on group social experiences and real-life meetups (e.g., BFF groups and Plan app) show promising early traction, particularly among Gen Z.
Outlook for shipping major product enhancements, including a fundamental shift away from swipe, is pushed to early 2027, delaying anticipated catalysts for user and revenue growth.

BP p.l.c.

BP.L Q2 2026

Reported: 2026-08-07

BP's shares fell 6.7% following the earnings release, reflecting investor disappointment primarily with production headwinds and ongoing cost challenges. Lower upstream volumes, margin pressures in refining, and cautious remarks on capital allocation and portfolio complexity weighed on sentiment.

Key takeaways

Upstream production declined 6% sequentially to 2.2 million barrels of oil equivalent per day, impacted by seasonal maintenance, Middle East disruptions, and operational issues in the North Sea and Indonesia.
Refining throughput fell 4% quarter-over-quarter due to higher planned turnarounds and reduced availability.
Underlying profit was $5.7 billion, up $2.5 billion from Q1, supported by downstream and trading, but offset by operational challenges upstream.
Net financial obligations decreased by $7 billion, yet management emphasized the balance sheet remains a priority, noting too much cash is still being used to service liabilities.
CEO highlighted ongoing structural cost issues and portfolio complexity, underscoring the need for simplification and disciplined capital allocation to improve returns and cash generation.

Brightstar Lottery

BRSL Q2 2026

Reported: 2026-08-07

Brightstar's shares gained 11.8% post-earnings, driven by better-than-expected profitability, strong cash generation, and encouraging growth in key metrics including global same-store sales and iLottery wagering.

Key takeaways

Global same-store sales rose 1.5% in Q2, accelerating slightly from Q1, led primarily by stronger U.S. sales tied to multistate jackpots and instant/draw games.
iLottery wagers increased 22% in the first half, with particularly strong growth in Italy (23%) and the U.S. (29%), supported by new digital offerings and expanded retail activation efforts.
Cash generation was significant, funding $140 million in shareholder returns year-to-date as well as the final Italy Lotto license payment, while maintaining a solid balance sheet.
Ongoing investments in Italy and Brazil digital and retail lottery expansions position Brightstar for revenue and profit inflection in the second half of the year.
Adjusted EPS and cash flow multiples suggest a compelling valuation relative to dividend yield and growth outlook.

Banco Santander-Chile

BSANTANDER.SN Q2 2026

Reported: 2026-08-07

Banco Santander-Chile's shares rose modestly by 2.1% post-earnings, reflecting a result that aligned with investor expectations amid a challenging economic backdrop and cautious outlook. The bank demonstrated stable execution but did not deliver clear catalysts to drive a stronger market response.

Key takeaways

The Chilean economy is slowing, with 2026 GDP growth forecast revised down to close to 1%, pressured by inflation, weak household disposable income, and soft construction activity.
Inflation remains elevated at 4.3% annually, with short-term expectations rising, driven largely by food prices and external cost pressures.
Unemployment rose seasonally to 9.3%, underscoring weak labor market conditions amid economic deceleration.
Banco Santander-Chile is pursuing a digital transformation combined with physical presence, aiming to enhance customer experience, deepen transactionality, and diversify income streams.
Regulatory developments, including corporate tax reductions and housing subsidies, may support future growth, though near-term macro headwinds warrant continued caution.

Caterpillar Inc.

CAT Q2 2026

Reported: 2026-08-07

Caterpillar shares rose 4.9% following Q2 results driven by stronger-than-expected sales volume growth in Construction Industries and Resource Industries, along with margin upside from tariff recoveries that offset elevated SG&A and R&D expenses.

Key takeaways

Quarterly sales and revenues reached a record $20.5 billion, up 24% year-over-year, led by broad strength across all three segments.
Adjusted operating profit margin was 21.9%, supported by $392 million in IEEPA tariff recoveries and lower-than-expected tariff costs, partially offset by higher operating expenses.
Sales to users grew 22% in Construction Industries, driven by strong rental fleet loading and demand in North America and solid growth in Europe and Africa.
Resource Industries sales to users rose 17%, with broad gains in mining, heavy construction, quarry, aggregates, and international rail deliveries.
Power & Energy sales to users increased 33%, powered by a 72% jump in power generation demand, particularly large gensets and turbines for data centers.

Coca-Cola HBC AG

CCH.L Q2 2026

Reported: 2026-08-07

Coca-Cola HBC’s stock rose modestly by 1.9% following half-year results showing volume-led revenue growth and margin expansion, but the market withheld a stronger reaction likely due to cautious outlook signals or factors not detailed in the transcript.

Key takeaways

Organic revenue increased 9.6%, supported by 7.5% organic volume growth, with acceleration to 5.8% volume growth in Q2.
Gross margins expanded significantly despite higher marketing spend; comparable EBIT rose 15.2% with margins up 60 basis points.
Sparkling beverages volume up 6.4%, led by continued strong performance of Trademark Coke and particularly Coke Zero Sugar Zero Caffeine, which showed triple-digit volume growth.
Energy category volumes surged over 25%, driven by Monster innovations and sports partnerships.
Coffee volumes declined overall but grew in the out-of-home channel by 24.5%, reflecting strategic channel shift; stills volumes increased 5.2%, driven by water and sports drink segments.

CDW Corporation

CDW Q2 2026

Reported: 2026-08-07

Shares fell 7.8% following the earnings release as investors were likely disappointed by continued deceleration in Education segment growth, margin pressure from pricing volatility, and a cautious outlook on spending despite top-line gains.

Key takeaways

Net sales rose 10% to $6.6 billion, driven by broad demand but with notable weakness in Education, which grew only about 1% amid funding constraints and fulfillment timing issues.
Commercial and Government segments showed solid growth at 9% and 14%, respectively, led by infrastructure modernization and federal momentum.
International operations surged 23%, with Canada and the U.K. experiencing mid-teens or better local currency growth.
Hardware revenue increased 10%, benefiting from AI readiness investments, but pricing pressures led to margin compression despite higher average selling prices on notebooks and desktops.
Management maintained a cautious tone on customer spending patterns, reflecting ongoing volatility and uncertainty in technology purchasing cycles.

Community Healthcare Trust Incorporated

CHCT Q2 2026

Reported: 2026-08-07

Shares dropped 12% as investors reacted negatively to the company’s dividend cut and cautious outlook on near-term growth, signaling concerns about decelerating cash returns and uncertain deal closures.

Key takeaways

Quarterly dividend reduced from $0.48 to $0.33 per share to retain $25-$30 million in capital for acquisitions, indicating pressure on immediate shareholder returns.
Strategic plan focuses on occupancy improvement, portfolio reinvestment, capital recycling, and accelerated acquisitions, but tangible results remain prospective.
Occupancy target set at 90.5% by year-end with a path to 92% over 18 months, reflecting gradual leasing progress (100,000+ sq ft leased year-to-date).
Capital recycling generated $38.5 million net proceeds from 7 properties sold; $70 million more assets are currently on the market.
Pending acquisition pipeline expected to reach $85-$90 million in 2026, but key inpatient rehab facility deals and behavioral hospital transaction remain subject to closing risks.

Cencora Inc.

COR Q3 2026

Reported: 2026-08-07

Cencora’s stock rose 6.1% following the Q3 report, driven by double-digit adjusted operating income growth and a raised fiscal 2026 EPS guidance, signaling investor approval of the company's execution and strategic positioning in specialty pharmaceuticals.

Key takeaways

Adjusted operating income grew double digits in Q3, underpinning profitability momentum.
Executed $1 billion in opportunistic share repurchases, supporting a 12% increase in EPS for the quarter.
Raised fiscal 2026 EPS guidance, reflecting management’s confidence in continued operational execution and portfolio strength.
Specialty pharmaceutical platform advances and digital transformation initiatives, including AI-driven demand forecasting, highlight strategic focus areas.
New CFO and CHRO appointments signal strengthened leadership continuity and commitment to talent development.

Circle Internet Group

CRCL Q2 2026

Reported: 2026-08-07

Circle’s Q2 results were largely in line with expectations, as reflected by a flat stock reaction despite solid top-line growth and regulatory progress. Investors appear to have weighed the company’s steady operational metrics against the absence of significant upside surprises.

Key takeaways

USDC in circulation grew 20% year-over-year to $73.3 billion.
Total revenue and reserve income reached $701 million, with adjusted EBITDA margins remaining stable.
Average daily USDC minting and redemption hit $1.9 billion, up 105% year-over-year.
On-chain transaction volume grew 151% year-over-year, averaging $163 billion daily in Q2.
Circle secured its OCC National Trust Bank charter and additional trust charter from New York, underpinning regulatory credentials.

Cytek Biosciences Inc. Common Stock

CTKB Q2 2026

Reported: 2026-08-07

Shares declined 2.8% after the Q2 report, reflecting investor caution despite steady revenue growth, with margin pressures and weakness in EMEA likely weighing on sentiment.

Key takeaways

Q2 revenue grew 6% year-over-year to $48.1 million, driven by double-digit growth in U.S. and China markets.
U.S. revenue increased 18% to $28.2 million, supported by gains in academic and government sectors and service business.
EMEA revenue declined approximately 8% year-over-year, impacted by ongoing regional budgetary constraints.
Total APAC revenue was flat, with strong growth in China offset by softness elsewhere in the region.
Recurring revenue from reagents and services rose 8% to $18.5 million, now 35% of trailing twelve-month revenue, up from 32% a year ago.

Clearway Energy, Inc.

CWEN Q2 2026

Reported: 2026-08-07

Clearway Energy's shares rose 3.5% following its Q2 2026 report, driven by strong visibility into growth projects and reaffirmation of its 2027 CAFD target despite a narrowed 2026 guidance range due to transitory weather impacts.

Key takeaways

2026 CAFD guidance was lowered to a range of $430 million to $470 million due to low wind resource in the first half of the year.
Reaffirmed 2027 CAFD per share target of $2.70 or better, with growing confidence in exceeding 2030 financial goals.
Approximately $3 billion of corporate capital deployment planned from 2026 through 2029, with over 70% of growth investments commercialized and in view.
Continued progress on wind fleet enhancements and long-term power purchase agreements, improving cash flow predictability.
Pipeline of late-stage solar-plus-storage projects totaling over 4 GW across 2028 and 2029 vintages signals robust medium-term growth runway.

DBS Group Holdings Ltd

D05.SI Q2 2026

Reported: 2026-08-07

DBS shares showed limited reaction, rising just 0.8% after reporting quarterly earnings with modest profit growth and stable asset quality, reflecting a largely in-line performance absent of clear upside or downside surprises.

Key takeaways

Second quarter net profit rose 9% year-on-year to a record $3.08 billion; half-year net profit advanced 5% to $6.01 billion.
Net interest income declined 2% year-on-year to $3.58 billion due to lower interest rates, partially offset by balance sheet growth and proactive hedging.
Fee income jumped 25% year-on-year to $1.46 billion, driven by wealth management and transaction services hitting record levels.
Total allowances fell 15% quarter-on-quarter to $113 million, with specific allowances at 16 basis points of loans, remaining below historical averages.
Expenses increased 3% to $2.35 billion mainly from higher staff costs; cost-to-income ratio steady at 39%.

Dave Inc. Class A Common Stock

DAVE Q2 2026

Reported: 2026-08-07

Shares tumbled 14.9% following earnings as investors rejected the company’s overly optimistic outlook and signs of margin pressure despite solid growth in revenues and user acquisition.

Key takeaways

Revenue grew 30% year-over-year to $171 million, continuing a strong topline trajectory.
Adjusted EBITDA rose 48% to $76 million with a 44% margin, though market reaction suggests concerns over margin sustainability.
Member additions accelerated 32% year-over-year with 951,000 new members; customer acquisition cost (CAC) held steady at $19.
ExtraCash originations increased 27% to $2.3 billion, with average loan size reaching $215 amid recent fee cap removals.
The market likely discounted the positive results due to cautious outlook on new product monetization timelines and possible pressure from recent pricing changes affecting long-term margins.

Ginkgo Bioworks Holdings Inc. Class A Common Stock

DNA Q2 2026

Reported: 2026-08-07

Shares plunged 9.3% following a steep 48% revenue decline and continued margin pressure, signaling investor disappointment with significant top-line deceleration and ongoing elevated losses despite cost-cutting efforts.

Key takeaways

Q2 revenue dropped 48% year-over-year to $20 million, reflecting sharp deceleration in core business.
Adjusted EBITDA loss widened to $36 million from $25 million a year ago, indicating margin compression despite reduced operating expenses.
Net loss from continuing operations increased to $57 million from $53 million in Q2 2025.
Cash burn rose to $45 million in Q2, up from $38 million the prior year, despite restructuring and cost controls.
Guidance maintained for 2026 cash burn of $125 million to $150 million, showing cautious outlook without improvement in near-term profitability.

Physicians Realty Trust

DOC Q2 2026

Reported: 2026-08-07

Shares declined 2.4% following the report, reflecting investor caution despite solid leasing in outpatient medical and growth in senior housing, likely due to margin pressures and a tempered outlook on near-term growth acceleration.

Key takeaways

FFO as adjusted came in at $0.46 per share with net debt-to-EBITDA of 4.7x, indicating a stable but leveraged balance sheet.
Outpatient medical leasing remained strong with 1.2 million square feet executed in Q2, including 327,000 square feet of new leases, continuing positive momentum.
Senior housing same-store occupancy increased by 260 basis points while NOI grew 19%, driven by Janus Living’s accelerating footprint and unique deal structure.
The company completed a $1 billion strategic partnership with Brookfield on outpatient medical assets, providing capital recycling and expanding alternative equity capital sources.
Management highlighted cautious capital allocation and patience on acquisitions or buybacks given current market conditions and the cost of debt relative to cap rates.

Dynatrace, Inc.

DT Q1 2027

Reported: 2026-08-07

Dynatrace's shares rose 6.9% following its Q1 report, reflecting better-than-expected subscription revenue and ARR growth driven by strong enterprise demand and early traction in AI observability monetization.

Key takeaways

Total ARR grew 17%, with net new ARR at $85 million, marking a 66% increase and 41% organic growth.
The company reported record new logo growth of over 160%, supporting broad-based demand.
Both total and subscription revenues came in above the high end of guidance, underpinning the positive market reaction.
Non-GAAP operating margin was 29%, reflecting disciplined expense management amidst investment in growth areas.
Early AI-related monetization initiatives contributed to increased consumption and expanded platform adoption, underscoring Dynatrace’s positioning in a rapidly evolving observability market.

Duolingo Inc. Class A Common Stock

DUOL Q2 2026

Reported: 2026-08-07

Shares fell 11% as investors were disappointed by cautious full-year bookings guidance and modest margin improvement despite accelerating user growth. Market reaction reflects skepticism that rising DAUs will translate into near-term revenue gains given ongoing experimentation and gradual monetization.

Key takeaways

Daily Active Users (DAUs) grew 23% year-over-year in Q2, accelerating from Q1, driven by product experimentation and user retention initiatives like the Streak Revival campaign.
Full-year bookings growth guidance was maintained at approximately 11%, despite current user momentum, signaling a deliberate restraint on near-term revenue expectations.
Gross margin outlook was marginally raised to ~70% for 2026, up from 69%, primarily due to AI-driven cost savings and content improvements.
Adjusted EBITDA margin guidance increased to around 25.5-26.5%, reflecting disciplined expense management despite investments.
Free cash flow remains robust, with $79 million generated in Q2 and $1.3 billion cash on hand; $44 million of stock buybacks executed during the quarter.

Devon Energy Corporation

DVN Q2 2026

Reported: 2026-08-07

Shares declined 2.1% following Q2 results as investors appeared cautious despite operational execution and synergy progress. The market likely weighed ongoing integration risks and the lack of a materially improved outlook given the merger and capital deployment updates.

Key takeaways

Adjusted free cash flow totaled $1.7 billion, supported by oil production 2% above the midpoint of guidance and capital spending 2% below plan.
The company announced a $1 billion synergy target with over 350 initiatives identified in the first 100 days post-merger with Coterra.
Permian inventory was enhanced by acquiring 400 federal lease locations at an effective cost of roughly $4 million each (after royalty adjustments), emphasizing long-term resource depth.
Dividend was raised 33%, and an $8 billion buyback program was initiated alongside $1.25 billion of debt reduction completed for 2026.
Integration progress is underway, but investors may remain cautious about execution risks and the timing of synergy realization.

e.l.f. Beauty, Inc.

ELF Q1 2027

Reported: 2026-08-07

Shares of e.l.f. Beauty rose 5.1% following a stronger-than-expected quarter driven by robust net sales growth and an upgraded fiscal 2027 outlook. The company demonstrated strength across its diversified brand portfolio and signaled continued momentum in innovation, marketing, and international expansion.

Key takeaways

Net sales increased 36% in Q1, marking the 30th consecutive quarter of sales growth.
Fiscal 2027 net sales growth guidance raised to 18–20%, up from the previous 12–14% range.
Diversification efforts showing results: non-e.l.f. brands now represent over 30% of sales; skin care sales increased from 10% to nearly 25%; digital penetration grew from 18% to 30%.
Supply chain diversification progressing with expected 60% production outside China by fiscal year-end, reducing geographic concentration risk.
Strategic focus on community-led innovation and disruptive marketing to maintain category leadership and brand awareness, including expanding international presence notably with Boots in the U.K. and Sephora in Brazil.

Siemens Energy AG

ENR.DE Q3 2026

Reported: 2026-08-07

Siemens Energy’s stock edged up 1.9% following Q3 results that showed continued profit margin expansion and progress in turning around its wind segment, but investors appear to have tempered enthusiasm amid cautious outlook commentary and ongoing portfolio transition discussions.

Key takeaways

Revenue reached EUR 17.9 billion, with order intake and revenue both increasing this quarter.
Profit before special items tripled year-over-year, driving a margin improvement to 14.2% for Q3.
Siemens Gamesa’s wind business reported a positive quarterly result for the first time in 15 quarters, signaling progress toward the 2026 breakeven target.
The Middle East accounted for a significant portion of demand, roughly 30% of gigawatts in large projects, with no impact yet from regional conflict.
Management reiterated confidence in guidance and seasonality but emphasized ongoing strategic portfolio considerations, including potential carve-outs due to differing capital allocation needs across segments.

EOG Resources, Inc.

EOG Q2 2026

Reported: 2026-08-07

EOG's shares declined 5.1% following earnings as investors reacted to indications of deceleration and a more cautious outlook despite record cash flow metrics and operational achievements. The tempered market response suggests concerns about the sustainability of growth and the evolving macro environment.

Key takeaways

Adjusted earnings per share, adjusted cash flow per share, and free cash flow all reached record levels, reflecting operational execution and oil price support.
Oil production has increased 22% and total production 60% since early 2022, with adjusted cash flow per share up 44% and dividends up 36%.
The company highlighted supply disruptions related to the Iran conflict as a key factor supporting higher near- and medium-term oil prices but acknowledged ongoing volatility.
EOG is advancing exploration projects internationally and domestically, including encouraging early results from UAE unconventionals averaging over 25,000 barrels of oil per well in the first 30 days.
Despite operational strengths, the cautious tone on commodity price volatility and geopolitical risks likely tempered investor enthusiasm, contributing to the negative stock reaction.

Exelixis, Inc.

EXEL Q2 2026

Reported: 2026-08-07

Shares fell 6.8% as investors reacted negatively to the company's modest guidance revision citing slower-than-anticipated growth in the NET indication and more cautious near-term revenue ramp expectations.

Key takeaways

Total revenues for Q2 2026 were approximately $629 million, with cabozantinib franchise net product revenues of $573 million.
U.S. cabozantinib franchise sales grew about 10% year-over-year, while global cabozantinib revenues increased roughly 13% year-over-year.
Guidance was lowered modestly due to a slower ramp in the NET indication reflecting patient population and histology characteristics.
Gross-to-net deductions increased, with Q2 at 29.5%, driven by lower co-pay assistance offset partially by increased 340B utilization; full-year gross-to-net expected between 30%-31%.
Management emphasized disciplined expense management and maintained free cash flow projections despite investment in R&D and pipeline expansion.

Expedia Group, Inc.

EXPE Q2 2026

Reported: 2026-08-07

Shares declined 1.8% following Expedia's Q2 report as investor confidence was tempered by Europe’s continued travel weakness and modest incremental demand from the World Cup, despite margin expansion and a raised full-year outlook.

Key takeaways

Booked room nights rose 6%, driven by mid-single digit growth in the U.S., low single digits in EMEA, and low double digits in the rest of the world; Europe remained pressured by macro headwinds and reduced air capacity.
Consumer bookings grew 8%, led by strongest U.S. growth in 15 quarters.
Adjusted EBITDA margins expanded nearly two points due to tight expense management and marketing leverage.
B2B segment maintained momentum with 20 consecutive quarters of double-digit growth.
Management raised full-year guidance based on H1 results and ongoing trends.

FI

Simplify Macro Strategy ETF

FIG Q2 2026

Reported: 2026-08-07

Shares fell sharply by 11.6% as investors reacted negatively to signs of deceleration underlying the results and cautious commentary about growth sustainability, despite solid headline revenue and early AI monetization progress.

Key takeaways

Revenue grew 48% year-over-year to $370 million, marking the third consecutive quarter of accelerated growth.
Net dollar retention remained strong at 136%, indicating good customer expansion within existing accounts.
Non-GAAP gross profit dollars increased 40% year-over-year with 10% operating margin, impacted by typical seasonal effects.
AI monetization commenced fully in Q2, showing promising engagement though no explicit revenue contribution details were provided.
Management emphasized large opportunity with new AI-driven features but highlighted ongoing challenges such as potential product complexity and the competitive landscape, suggesting some investor caution about forward growth trajectory.

Flutter Entertainment plc

FLUT Q2 2026

Reported: 2026-08-07

Flutter's shares fell 11.4% following the Q2 report, reflecting investor disappointment with the company's cautious outlook and decision to prioritize customer incentives over near-term profitability amid a sluggish U.S. sports betting market and necessary investment spend.

Key takeaways

U.S. revenue declined 6% year-over-year, impacted by favorable sports results that returned cash to customers and subdued market growth of approximately 5% in H1.
Management shifted strategic focus from margin expansion to customer acquisition and engagement, increasing generosity through improved value propositions, which will weigh on near-term earnings.
Operational progress in prediction markets was slower than planned, though the company expects about $50 million in market-making revenue for the year as it expands offerings.
New leadership in the U.S. market is being credited with facilitating improvements, but investor concerns remain over subdued overall market trends and near-term profitability.
FanDuel's enhanced loyalty and product features delivered improved engagement, but limited impact on reversing the underlying top-line pressure.

Fresenius SE & Co. KGaA

FRE.DE Q2 2026

Reported: 2026-08-07

Fresenius shares jumped 5.2% post-earnings on raised full-year core EPS guidance and margin expansion, reflecting investor approval of solid earnings growth and operational leverage across its diversified healthcare platforms.

Key takeaways

Core EPS grew 14% at constant currency, outpacing top-line growth and driven by strong earnings progression in Fresenius Kabi and Helios.
EBIT increased 10% on a constant currency basis, with group EBIT margin improving 60 basis points to 12.3%.
Return on invested capital (ROIC) strengthened to approximately 7%, about 200 basis points above 2022 post-transformation levels.
Kabi delivered 12% organic growth with margins near 18%, benefiting from scaling innovation-led growth vectors in biopharma, nutrition, and MedTech.
Helios maintained a resilient EBIT margin at 10.6% despite regulatory uncertainties, demonstrating steady operational performance in care services.

Freshpet, Inc.

FRPT Q2 2026

Reported: 2026-08-07

Freshpet’s shares jumped 7% after the company reported second quarter results that beat expectations on growth and margins, prompting an upward revision to full-year sales and adjusted EBITDA guidance.

Key takeaways

Delivered strongest growth rate in over a year, driven by a 13% combined increase in household penetration and buying rate, with buying rate alone up 7% over the past 52 weeks.
Achieved highest adjusted gross margin since Q1 2020, underscoring manufacturing scale and cost advantages.
Raised 2026 sales and adjusted EBITDA guidance ranges, reflecting confidence despite ongoing macroeconomic pressures like higher gas prices and cautious consumer spending.
Digital orders grew 41%, now comprising 16.7% of total sales, supported by an expanding fridge network that also enables omnichannel fulfillment.
Total distribution points expanded 13% in Q2, with further selective expansion planned in rural lifestyle retail channels and club stores.

Freshworks Inc. Class A Common Stock

FRSH Q2 2026

Reported: 2026-08-07

Shares declined 2.1% post-earnings, reflecting some investor caution despite stable growth and sustained profitability. While core metrics held steady, the market appears to be digesting a cautious outlook and lack of clear upside catalysts.

Key takeaways

Q2 revenue grew 16% year-over-year to $237.4 million, maintaining consistent top-line growth.
Non-GAAP operating margin remained healthy at 24%, continuing a streak of eight quarters achieving Rule of 40.
Employee Experience (EX) ARR expanded 24% in constant currency to $567 million, now comprising about 59% of total ARR.
Growth driven by increased large customer deals, with 40% of total ARR coming from customers contributing over $100,000 annually.
Management highlighted progress on AI integration and upmarket expansion, but no explicit guidance gains or margin expansion to offset cautious investor sentiment.

Fastly, Inc.

FSLY Q2 2026

Reported: 2026-08-07

Fastly's shares dropped 9.1% after earnings as investors reacted negatively to cautious outlook comments that tempered the otherwise solid execution. Despite strong revenue growth and margin expansion, the market focused on concerns about sustainability and future headwinds.

Key takeaways

Revenue rose 23% year-over-year to $183 million, hitting the high end of guidance.
Gross margin improved to a record 65.8%, with operating income of $27 million and an operating margin of 14.7%, both above guidance.
Net retention rate reached 117%, the highest in over three years, supporting ongoing platform expansion.
Security segment showed robust 43% growth driven by cross-sell and upsell of threat defense and governance products.
Despite operational discipline and cash flow positivity, cautious management commentary on future growth dynamics appeared to weigh on investor sentiment.

fuboTV Inc.

FUBO Q3 2026

Reported: 2026-08-07

FuboTV shares dropped 5.9% following Q3 results, primarily due to cautious subscriber growth outlook and margin pressure despite positive engagement around major live events and advertising improvements.

Key takeaways

Subscriber growth benefited from the 2026 World Cup and NBA Finals, particularly in Spanish-language services, but management signaled expectations of some post-event attrition.
Monetization of advertising inventory improved with double-digit increases in CPM and fill rates after migrating to Disney's ad server, though gains remain early-stage.
The company highlighted enhanced subscriber acquisition through ESPN referrals, showing higher conversion and retention rates than other channels.
No explicit guidance upgrade was provided, suggesting investor concerns about future growth sustainability and potential margin compression.
Management framed optimism around integration with Hulu and Disney+, but the market reaction indicates skepticism over near-term execution risks and outlook.

GlobalFoundries Inc. Ordinary Shares

GFS Q2 2026

Reported: 2026-08-07

Shares declined 3.2% as investors reacted negatively to cautious commentary around near-term growth prospects despite strong execution in key areas. The modest guidance tone and lack of acceleration in broader revenue streams appear to have weighed on sentiment.

Key takeaways

Revenue and non-IFRS profitability were reported at or near the high end of guidance ranges, indicating solid execution.
Comms infrastructure and data center end markets drove over 60% year-over-year growth, led by optical networking on silicon photonics and silicon germanium platforms.
Quantum Technology Solutions launched with early customer engagements and a significant $375 million U.S. government grant, signaling a long-term strategic focus.
The AI data center segment showed momentum with seven new optical networking design wins and projected more than doubling of silicon photonics revenue in 2026.
Despite these positives, market reaction suggests investor concern about deceleration or cautious outlook in other business segments or overall near-term growth visibility.

Gilead Sciences, Inc.

GILD Q2 2026

Reported: 2026-08-07

Shares in Gilead moved modestly higher by 0.5% following the quarter, reflecting a broadly in-line result with no major surprises or disappointments despite raised HIV growth guidance.

Key takeaways

Total product sales (excluding Veklury) increased 10% year-over-year to $7.6 billion, driven by HIV, oncology, and liver disease businesses.
HIV sales grew 12% year-over-year to $5.7 billion, led by Biktarvy, Descovy, and Yeztugo; full-year HIV sales guidance was raised to 9%–10% growth from 8%.
PrEP sales doubled year-over-year, exceeding $1 billion for the first time with a $4 billion annual run rate, significantly outpacing the 14% growth in the U.S. prevention market.
Trodelvy oncology sales rose 26% year-over-year, supported by label expansions and new approvals.
Livdelzi liver disease sales more than doubled, and the company launched Hepcludex for hepatitis delta virus in the U.S. this quarter.

Glencore plc

GLNCY Q2 2026

Reported: 2026-08-07

Glencore’s shares were modestly higher (+1.4%) following a broadly in-line half year report with stable operational performance and maintained guidance. The market response suggests investors acknowledge steady delivery but remain cautious amid offsetting cost pressures and only moderate upside signals.

Key takeaways

Adjusted industrial EBITDA came in at $6.5 billion, supported by higher metals prices despite increased input costs, including diesel.
Marketing EBIT nearly reached record levels at $3.3 billion, driven by volatile energy and freight markets creating trading opportunities, especially in oil, gas, and coal.
Total adjusted EBITDA for the half was $10.1 billion, with net debt at $10.2 billion and funds from operations up 158% to $8.1 billion, aiding a $1.5 billion shareholder return (cash plus buyback).
Copper production projects remain on track with notable schedule improvements at Alumbrera (now expected late 2027 vs. H1 2028 previously) and progress on key permitting and land acquisitions across multiple jurisdictions.
Despite solid delivery, cost headwinds and uneven segment contributions temper enthusiasm, reflected in the muted market move rather than a stronger positive reaction.

Galaxy Digital

GLXY Q2 2026

Reported: 2026-08-07

Shares dropped 11.8% following earnings as investors reacted negatively to a cautious outlook amid ongoing crypto market headwinds, a continuing digital asset price decline, and significant margin pressure that suppressed profitability despite operational progress in data centers.

Key takeaways

Reported GAAP net loss of $85 million, or $0.09 per share, driven primarily by the depreciation of digital asset prices.
Firm-wide adjusted EBITDA remained negative at $77 million, reflecting margin compression in the Treasury and Corporate segment which posted an adjusted gross loss of $42 million.
Data center revenues began contributing as Phase I of Helios came online, supporting a modest operating segment adjusted EBITDA of $1 million, up from Q1 but not yet offsetting overall losses.
Digital Asset segment gross profit increased 34% sequentially to $66 million, driven by market share gains and improved electronic trading despite a 7% decline in trading volumes and a depressed crypto pricing environment.
Cash and stablecoins declined 6% sequentially to $2.5 billion due to ongoing investments in data center build-out, while net digital asset holdings decreased 15% reflecting both asset sales and price depreciation.

GRAIL, LLC

GRAL Q2 2026

Reported: 2026-08-07

GRAIL’s shares dropped 12.8% following earnings as investors reacted negatively to cautious outlook signals and indications of deceleration despite ongoing revenue growth in Galleri test sales.

Key takeaways

Galleri test revenue rose 24% year-over-year in Q2 to $42.6 million, reaching over $80 million for the first half of 2026, driven by a 35% increase in test volume to 61,000 units.
Physician adoption is increasing, supported by expansion of sales and medical teams, with positive initial feedback from new hires in the field.
Despite strong clinical validation and recently presented data from large trials, the primary endpoint of the NHS-Galleri trial—reduction in late-stage cancers—was not met, which may weigh on investor confidence.
GRAIL completed a $110 million financing with Samsung to support international expansion, notably in South Korea and broader Asia, aiming to diversify growth avenues.
Management emphasized ongoing efforts toward FDA approval and reimbursement, but cautious outlook on near-term commercial ramp factors into market skepticism.

Granite Real Estate Investment Trust

GRT-UN.TO Q2 2026

Reported: 2026-08-07

Shares of Granite REIT declined by 0.7% after quarter two results as the market weighed nonrecurring charges and a cautious outlook despite healthy same-property NOI growth and a narrowed guidance range.

Key takeaways

Same-property NOI increased 8.3% on a constant currency basis, supported by leasing spreads of 7% and higher occupancy by 220 basis points year-over-year.
FFO per unit was $1.56, down $0.01 sequentially but up 12.2% year-over-year; excluding nonrecurring items, normalized FFO per unit would have improved modestly quarter-over-quarter.
AFFO per unit declined $0.15 sequentially to $1.26, impacted by elevated maintenance capital expenditures of $14.7 million, up $7 million from Q1.
Nonrecurring negative impacts totaling $1.3 million included a $2.6 million provision related to a tax audit and a one-time lease termination fee, reducing FFO and AFFO by approximately $0.02 per unit.
Guidance was narrowed with expected 2026 FFO per unit growth of 7–8% (to $6.30–$6.40) and AFFO growth of 4–6%, but investors remain cautious given increased G&A and capital expenditure pressures.

Green Thumb Industries Inc.

GTBIF Q2 2026

Reported: 2026-08-07

Shares of Green Thumb Industries fell 5.5% after the earnings release, driven by investor concerns around continued price compression and a cautious outlook despite stable revenue growth.

Key takeaways

Q2 revenue grew 5% year-over-year to $307 million, reflecting underlying business scale but modest top-line momentum.
Normalized EBITDA reached $84 million, or approximately 28% of revenue, indicating margin pressure amid ongoing price compression.
Cash flow from operations was $29 million, supporting ongoing share repurchases totaling roughly $200 million returned since late 2023.
Management highlighted regulatory progress and potential federal rescheduling as long-term catalysts, but provided no firm near-term guidance upgrades.
Early signs of price stabilization in select markets were noted, though competitive dynamics and price pressure persist, keeping near-term outlook cautious.

Warrior Met Coal, Inc.

HCC Q2 2026

Reported: 2026-08-07

Warrior's shares jumped 10% following the quarter, driven primarily by margin expansion and record sales volumes that exceeded expectations, alongside more than $103 million in free cash flow generated as Blue Creek ramped up production.

Key takeaways

Free cash flow topped $103 million in Q2, turning the year’s midpoint free cash flow positive by $11 million.
Record sales volumes combined with improved pricing and a lower cost structure fueled significant margin expansion.
Pricing indices in the Pacific Basin rose 29% year-over-year, while US East Coast prices declined 7%, pressuring gross price realizations to 66% versus 80% last year.
Freight costs were materially higher (+37%), negatively impacting net selling prices despite stronger index pricing.
The product mix shifted 21% toward High-Vol A products with lower price realizations but benefiting from Blue Creek’s low-cost production, supporting margin gains going forward.

The Hackett Group, Inc.

HCKT Q2 2026

Reported: 2026-08-07

The Hackett Group's shares rose modestly by 1.8% following Q2 results that largely met expectations amid a cautious demand environment and an ongoing AI-driven business transformation. While revenue and adjusted EPS landed at guidance midpoint, investors appear cautiously optimistic about the upcoming pipeline strength and anticipated margin improvements in Q3.

Key takeaways

Revenue was $68.3 million before reimbursements, with adjusted diluted EPS of $0.34, both at the midpoint of management guidance.
Growth is driven by the gradual adoption of AI-enabled platforms (XT, AIX, AI XPLR) which accounted for over $30 million in new proposals late in the quarter.
The firm is transitioning from traditional consulting to a platform-led model aiming to improve delivery productivity and gross margins.
AI engagements are increasingly integrated into broader enterprise transformation projects rather than stand-alone AI initiatives, reflecting client caution.
Partnerships with IBM (currently paused), ServiceNow, TCS, and Genpact are expected to support pipeline expansion and future quarters.

Hess Midstream LP

HESM Q2 2026

Reported: 2026-08-07

Shares declined 0.8% following the earnings release, reflecting investor caution despite largely stable volumes and margin performance, as the incremental free cash flow declined modestly and third-quarter capital expenditures are expected to rise.

Key takeaways

Q2 adjusted EBITDA increased modestly to $314 million from $300 million in Q1, driven by lower operating expenses and higher revenues in gathering (+$7 million) and processing (+$3 million).
Adjusted free cash flow decreased 2% sequentially to approximately $232 million, pressured by increased net interest expenses and higher capital spending guidance.
Throughput volumes were broadly steady, with gas processing volumes slightly higher offset by flat to lower oil volumes, consistent with their annual guidance.
Third-quarter guidance indicates adjusted EBITDA will remain roughly flat sequentially ($310-320 million), but adjusted free cash flow is expected to decline due to higher capital expenditures.
The company reiterated full-year 2026 adjusted free cash flow guidance of $910 million to $960 million, though EBITDA is projected to be roughly flat year-over-year at the midpoint, signaling no acceleration in growth.

Hecla Mining Company

HL Q2 2026

Reported: 2026-08-07

Hecla's shares rose 3.1% on the quarter, propelled by strong free cash flow generation and record production at key mines, underscoring investor confidence in the company's operational execution and project pipeline.

Key takeaways

Revenue declined sequentially to $334 million from $411 million due to lower metal prices and timing of concentrate sales, not production issues.
Adjusted EBITDA doubled year-over-year to $199 million, with all mines generating positive free cash flow; Greens Creek and Lucky Friday set site-level free cash flow records at $130 million and $88 million, respectively.
Silver production increased 8% sequentially to 4.2 million ounces, led by a new quarterly record of 1.5 million ounces at Lucky Friday.
Balance sheet strength improved with $483 million cash, no long-term debt beyond capital leases, and a fully undrawn $225 million revolver, providing financial flexibility.
Early-stage development of a low-capital intensity pyrite concentrate project at Greens Creek aims to add 1–1.2 million ounces of silver and 10,000–15,000 ounces of gold annually by late 2027 or early 2028.

Honeywell Aerospace Inc

HONA Q2 2026

Reported: 2026-08-07

Shares plunged 27.7% following Honeywell Aerospace’s earnings as investors were clearly disappointed by the supply chain disruptions that caused slower-than-expected production ramp and a revised, cautious outlook.

Key takeaways

Supply chain bottlenecks, concentrated in roughly 2% of critical suppliers, constrained factory volume growth despite strong demand and an 8% increase in orders year-over-year.
Management acknowledged underestimating the time required to resolve supplier issues, delaying the expected acceleration in output through the first half of 2026.
The company is investing over $1 billion to enhance supply resiliency and has initiated new production capacity expansions, with progress now reported as tangible but slower than hoped.
Despite near-term challenges, Honeywell Aerospace reiterated long-term 2030 financial targets and highlighted its innovation pipeline, including next-generation Anthem avionics moving toward commercialization.
The disappointing production ramp and cautious near-term outlook outweighed optimism around demand and technology, leading to a sharp negative market reaction.

Hiscox Ltd

HSX.L Q2 2026

Reported: 2026-08-07

Shares rose modestly by 1.9% following a mixed earnings update where retail growth momentum and margin improvement were offset by ongoing cycle management in London Market and a cautious repositioning of major property premiums.

Key takeaways

Reported a 10% increase in gross premiums written, with retail premiums leading growth (+$174 million), nearly matching full-year 2025 total.
Insurance service result rose 30%, reaching $255.4 million, reflecting improved operating leverage.
Combined ratio held at a healthy 90%, within guided ranges across segments: retail margin expanding toward 89–94%, London Market stable despite geopolitical headwinds, and reinsurance maintaining a strong 70% combined ratio.
London Market underwent targeted portfolio pruning, including a 24% reduction in major property premiums, offset by growth in structured solutions and downstream energy.
Continued technology investments, including AI-driven underwriting and customer self-service, aim to support sustainable growth and efficiency but have yet to materialize into material upside.

HubSpot, Inc.

HUBS Q2 2026

Reported: 2026-08-07

Shares plunged 18.7% as HubSpot’s cautious outlook and execution missteps drove investor disappointment. The deliberate extension of AI trial periods and pricing changes delayed revenue recognition, compounded by softer demand and lengthening sales cycles, signaling a pronounced deceleration in key growth drivers.

Key takeaways

Q2 revenue grew 17.5% year-over-year (constant currency), but the market focused on slowed momentum tied to AI adoption.
HubSpot introduced extended AI trials and outcome-based pricing to address customer demand for proof of value and cost predictability; however, these moves slowed purchasing decisions and added near-term headwinds.
Sales cycles lengthened with increased budget scrutiny and more C-suite and board-level involvement, reflecting heightened purchase hesitancy and budget optimization pressures.
Despite the headwinds, AI adoption metrics showed growth: Data agent customers rose 80% quarter-over-quarter, Prospecting agent up 28%, and Marketing Hub Pro+ customers activating AI-powered AEO reached 32%.
Upmarket deals over $120,000 ARR grew 38% year-over-year, and 64% of new Pro+ customers landed with multiple hubs, indicating pockets of strength amid the broader slowdown.

Hut 8 Corp.

HUT Q2 2026

Reported: 2026-08-07

Hut 8 shares dropped 17.2% following the earnings release as investors reacted negatively to signs of deceleration in key operational metrics and cautious commentary on near-term execution risks, despite ongoing progress in commercializing AI infrastructure projects.

Key takeaways

The company emphasized transitioning its platform from bitcoin mining towards AI infrastructure but acknowledged ongoing execution risks related to power origination and project construction timelines.
Hut 8 highlighted its ability to secure long-duration contracts with investment-grade counterparties, including three 15-year leases signed in the past nine months.
Current operations include approximately 700 megawatts supporting affiliated bitcoin mining, with greenfield AI campuses under construction reflecting strategic diversification.
Management underscored that their value creation model depends on a repeatable system for originating and financing projects, not on individual asset performance.
Despite strategic clarity, investor skepticism was apparent, likely due to cautious outlook language and the implied challenges in scaling and delivering on the expanding AI infrastructure opportunity.

Hyster-Yale Materials Handling, Inc.

HY Q2 2026

Reported: 2026-08-07

Hyster-Yale’s 5.2% stock gain reflects better-than-expected bookings growth and sequential improvements in revenue, operating performance, and cash flow, signaling cautious optimism despite ongoing profitability pressures.

Key takeaways

Bookings surged 17% sequentially to $680 million, more than doubling compared to Q2 2025, marking the fourth consecutive quarter of bookings growth.
Revenue increased 2% sequentially to $813 million as higher bookings began translating into shipments.
Operating loss narrowed to $18 million, a $10 million improvement from Q1, mainly driven by the lift truck business through favorable pricing and lower employee-related expenses.
Second quarter operating cash flow turned positive at $17 million, up approximately $50 million from Q1 thanks to disciplined working capital management.
The company confirmed continued market recovery progress but acknowledged volumes remain below optimal levels and profitability pressures persist.

iA Financial Corporation Inc.

IAG.TO Q2 2026

Reported: 2026-08-07

Shares rose modestly by 2.7% following the quarter, reflecting steady execution and diversification but no clear catalyst to drive a stronger market reaction.

Key takeaways

Core EPS came in at $3.68, up 5% year-over-year; reported EPS rose 25% to $4.28.
Net premiums, premium equivalents, and deposits increased 25% to $6.3 billion, supported by strong distribution platforms.
Wealth Management sustained growth with gross sales reaching $4.3 billion and net inflows of $934 million; individual segregated fund gross sales surged 52%.
Insurance Canada showed resilience with stable sales in individual insurance ($102 million) and 5% growth in direct written premium for auto and home insurance.
Capital position remained solid with solvency ratio at 137% and $1.1 billion of capital available; $347 million returned to shareholders via share buybacks.

Ibstock plc

IBST.L Q2 2026

Reported: 2026-08-07

Shares fell 6.9% after the half-year report as investors reacted negatively to clear volume deceleration, margin compression, and a subdued outlook that anticipates performance at the lower end of expectations. Despite pricing actions, declining demand and deliberate capacity cuts weighed heavily on results.

Key takeaways

Group revenue declined 15% year-on-year to £164.2 million, with a 10% like-for-like drop driven by weaker volumes and the disposal of non-core roofing assets.
Adjusted EBITDA fell 28% to £25.7 million, reflecting volume declines, cost inflation, and a £5-6 million EBITDA headwind from deliberate capacity and inventory management.
Clay segment revenue dropped 10% reported (8% core), with volume declines partially offset by positive pricing and market share gains; clay adjusted EBITDA fell to £23.4 million with margin contracting to 19.5%.
Concrete revenue fell 26% reported (11% like-for-like), impacted by weak residential and RMI demand, partially offset by modest rail and infrastructure improvements.
Management lowered full-year guidance to the lower end of market expectations, citing continued near-term market challenges; net debt-to-EBITDA leverage rose to 2.5x from 1.9x.

International Flavors & Fragrances Inc.

IFF Q2 2026

Reported: 2026-08-07

The stock responded positively with a 4.5% gain, driven by solid volume growth, disciplined margin management, and strong free cash flow generation, which support confidence in reaching full-year targets despite an uncertain macro environment.

Key takeaways

Continuing operations achieved 4% sales growth and 8% EBITDA growth in the first half of 2026, underpinned by volume increases and productivity gains.
Free cash flow improved significantly by $284 million year-over-year, reaching $378 million, supported by strong net working capital management.
The announced divestiture of the Food Ingredients business for approximately $4.3 billion at a 10x EV/EBITDA multiple marks a major portfolio simplification and refocus on higher-growth, higher-margin segments.
Stranded costs of about $100 million related to the divested Food Ingredients business are currently weighing on margins but are expected to be largely eliminated within two years through a remediation plan.
Management plans to deploy divestiture proceeds to reduce debt by over $1 billion and initiate a $2.5 billion share repurchase program, reflecting confidence in long-term value creation.

Innovex International, Inc.

INVX Q2 2026

Reported: 2026-08-07

Innovex shares rose 7.6% following a quarter that delivered revenue and adjusted EBITDA at the high end of guidance, alongside expanding subsea momentum and successful integration of recent acquisitions. Market sentiment clearly favored the company’s accelerating commercial traction and positive outlook across key international markets.

Key takeaways

Revenue reached $245 million and adjusted EBITDA $48 million, with a healthy 20% EBITDA margin, both near the top of guided ranges.
Successful acquisition of TCO Group broadened Innovex’s technology portfolio and geographical footprint, notably in Norway and the UAE, with growth potential highlighted but not yet reflected in purchase price.
Subsea business showed strong momentum, including a $20 million subsea tension riser package win in Malaysia and the first XPak trial completed in Asia Pacific, signaling improving offshore activity.
Innovative product deployments like the ArgoLATCH Subsea Release Plug in Brazil showcased integrated technology solutions that save time and cost for customers.
Activity surged in international markets such as Mexico and Saudi Arabia, with notable milestones including first surface wellhead delivery to Mexico and direct contracting in Saudi Arabia enhancing future growth prospects.

Innoviz Technologies Ltd.

INVZ Q2 2026

Reported: 2026-08-07

Innoviz's shares declined 1.9% post-earnings, reflecting investor caution despite record revenues. While the company is making promising strides into higher-margin defense markets, the market remained unimpressed by the modest near-term impact and cautious outlook on automotive growth and non-automotive ramp-up.

Key takeaways

Reported record quarterly revenues of $18.1 million driven by a mix of automotive and nascent defense/security sales.
Defense and security segment orders include the first multimillion-dollar Counter-UAS and perimeter security contract, though still early stages with revenues currently representing only a small portion of total.
Defense and security expected to grow from 1% of revenues in 2025 to 10% in 2026 and 20-30% by 2027, with higher ASPs driving gross margin upside.
Automotive business is progressing with multiple programs on track, including partnerships with a top 10 OEM and Mobileye’s robotaxi platform using nine Innoviz LiDARs per vehicle, though ramp timing and scale remain key uncertainties.
Balance sheet strengthened by a recent institutional offering to support defense expansion and automotive production ramp.

Joby Aviation Inc. Common Stock

JOBY Q2 2026

Reported: 2026-08-07

Shares rose 3.3% following Joby Aviation’s report, reflecting investor optimism driven by raised full-year revenue guidance and strong growth in Blade’s core business.

Key takeaways

Blade’s seats sold increased by over 50% year-over-year in Q2, marking its best Q2 performance on record.
Blade’s revenue grew 32% year-over-year in the first half of 2026, prompting Joby to raise full-year revenue guidance.
Blade’s New York to Hamptons route revenue grew by more than 40% year-over-year, supported by strong demand and route expansion.
Joby confirmed plans to complete first eIPP flights in Texas next month, advancing toward commercial service and regulatory milestones.
The company highlighted growing regulatory engagement globally and strategic partnerships, including a new multi-year agreement with Virgin Atlantic and a collaboration with Atoms, an AI infrastructure firm.

Klockner & Co SE

KCO.DE Q2 2026

Reported: 2026-08-07

Shares edged up modestly by 0.6% following Q2 results that showed stable revenues supported by pricing and shipment growth on a like-for-like basis but were weighed down by significant write-downs and increased operating expenses.

Key takeaways

Reported shipments decreased slightly year-over-year due to the divestment of 8 U.S. distribution sites; excluding divestments, shipments rose 4.3%.
Sales grew 3% reported and 12.1% on a divestment-adjusted basis, driven by higher average price levels across regions.
EBITDA before material special effects improved to EUR 63 million from EUR 56 million (adjusted prior year), supported by positive volume (+EUR 13 million) and price effects (+EUR 21 million), despite higher operating expenses (+EUR 27 million).
Gross profit declined notably to EUR 243 million from EUR 320 million due primarily to a non-recurring write-down at Becker.
Operating cash flow remained positive at EUR 10 million but decreased from the prior year, with net financial debt rising slightly to EUR 1.108 billion.

Kyndryl Holdings, Inc.

KD Q1 2027

Reported: 2026-08-07

Shares fell 4.8% as investors reacted negatively to signs of decelerating growth in legacy segments and cautious execution despite strength in consulting and hyperscaler partnerships. The disappointing market response reflects lingering concerns over margin pressure and slower-than-expected broader revenue expansion.

Key takeaways

Kyndryl Consult revenue grew 14% year-over-year with strong demand for AI-driven modernization and cybersecurity solutions.
Hyperscaler-related revenue streams increased 48%, driven by expanded alliances with AWS, Azure, and other partners.
Despite growth in targeted areas, ongoing headwinds persist in focus accounts due to longer sales cycles and customers buying hardware/software directly from IBM.
Profitability remains pressured; management expects higher-margin revenue from recent signings to improve adjusted pretax income to over $1.2 billion and free cash flow to $1 billion by fiscal 2028.
Workforce rebalancing and SG&A savings are planned but benefits will materialize mainly in the second half of the fiscal year.

CS Disco Inc. Common Stock

LAW Q2 2026

Reported: 2026-08-07

The 4.1% stock gain reflects investor approval of DISCO's accelerating growth in large matters and expanding wallet share with key customers, alongside positive early market reception of its new Unified Litigation Solution.

Key takeaways

Total revenue grew 13% year-over-year to $43.1 million, with software revenue also up 13% and services revenue rising 18%.
Adjusted EBITDA remained negative $3.4 million, with management targeting adjusted EBITDA positivity by Q4.
The newly launched Unified Litigation Solution aims to integrate facts and controlling law in a single platform, addressing unmet needs in litigation AI.
Early pilot feedback from prestigious litigation boutiques highlights demand for deeper contextual AI, validating DISCO’s long-term strategic vision.
Growth drivers remain large, complex matters and increased wallet share within existing large customers, supporting near- and medium-term revenue expansion.

Leidos Holdings, Inc.

LDOS Q2 2026

Reported: 2026-08-07

Leidos’ Q2 results outpaced expectations with revenue growth, margin expansion, and raised guidance, driving a strong 6.8% stock rally. Defense segment momentum and improved bookings were key contributors to investor optimism.

Key takeaways

Q2 revenue rose 7% year-over-year to $4.6 billion, with 4% organic growth.
Adjusted EBITDA margin held steady at a best-in-class 13.8%.
Operating cash flow hit a Q2 record near $800 million.
Book-to-bill ratio of 1.1 for the quarter, led by a robust 2.2 ratio in Defense.
Raised 2026 revenue midpoint by $100 million, EPS midpoint by $0.05, and operating cash flow guidance by $50 million, reflecting confidence in ongoing momentum.

Eli Lilly and Company

LLY Q2 2026

Reported: 2026-08-07

Lilly’s Q2 revenue growth and margin expansion outpaced expectations, driven by strong volume gains in key products like Mounjaro and Zepbound, pushing the stock up 6.8%. The market clearly rewarded the company’s robust commercial execution and positive pipeline developments.

Key takeaways

Revenue surged 48% year-over-year, fueled primarily by volume growth of Mounjaro, Zepbound, and contributions from Immunology, Oncology, and Neuroscience portfolios.
Gross margin improved to 86.3%, a 1.3 percentage point increase, reflecting favorable product mix and better production costs.
U.S. pricing declined 3% overall, or 9% excluding rebate and discount estimate adjustments, but volume growth offset price pressure.
Non-GAAP EPS rose to $8.38, including $3.03 in acquired intangible asset charges, compared to $6.31 last year (with $0.14 in charges).
Regulatory and commercial progress included approvals for Ebglyss maintenance dosing, Jaypirca expansions, and Foundayo launches in multiple international markets, supporting future growth prospects.

Limbach Holdings, Inc.

LMB Q2 2026

Reported: 2026-08-07

Limbach's shares plunged 37.8% post-earnings, reflecting investor disappointment with ongoing margin pressure and project timing issues that led to results falling short of expectations. The weak performance was exacerbated by softness in health and institutional markets and cautious near-term outlook despite strategic diversification efforts.

Key takeaways

Q2 results missed expectations due to project timing delays and continued softness in health and institutional markets, driving gross margin compression.
Bookings remained solid at $182 million, marking the third consecutive strong quarter and contributing to a $616 million total over three quarters.
Management highlighted strategic focus on diversification across data centers, industrial manufacturing, and geography to reduce reliance on any single vertical.
Acquisition of Simpcore aims to expand national footprint and data center exposure, while leveraging Limbach’s integrated operating model to improve margins long term.
Improvement in margins from prior acquisition Pioneer Power was noted (+1.5% gross margin improvement in H1 2026), but margin enhancement remains a multiyear target.

Dorian LPG Ltd.

LPG Q1 2027

Reported: 2026-08-07

Shares rose modestly by 2.0% following Dorian LPG’s Q1 2027 earnings, reflecting a solid underlying VLGC market but no clear breakthrough in financial metrics to drive a stronger rally. While the operational environment remains supportive, the modest stock reaction suggests investors are withholding enthusiasm pending clearer margin expansion or guidance updates.

Key takeaways

VLGC spot and COA voyages generated a strong TCE of $82,445 per day, boosted by Middle East disruption and elevated ton-mile demand.
U.S. LPG exports hit a record 20.8 million tons, contributing to increased market share and favorable freight conditions.
The company continues fleet renewal efforts, selling several vessels for net proceeds above $166 million and contracting a new dual-fuel VLGC for 2029 delivery.
Financially, Dorian ended the quarter with nearly $600 million in cash and a debt load reduced to roughly $473 million pro forma for recent sales, maintaining a conservative net leverage profile with a 9.7% net debt to capitalization ratio.
Operating costs are forecast at $26,000–$27,000 per day for the year ahead, excluding scheduled dry dock capital expenditures.

Louisiana-Pacific Corporation

LPX Q2 2026

Reported: 2026-08-07

LP Building Solutions shares slipped 1.2% following the quarter as investors digested continued OSB price weakness and margin headwinds in Siding, despite stable volume trends and cautious outlook commentary.

Key takeaways

Net sales declined to $664 million, down $90 million year-over-year, primarily due to lower OSB prices amid soft demand in North and South America.
EBITDA dropped $63 million to $79 million, reflecting the top-line impact and margin pressure from unexpected weather disruptions and freight capacity constraints.
Siding segment delivered a 26% EBITDA margin, aligning with guidance, with sales up 4% year-over-year driven by 7% price increases offsetting an 11% volume decline.
Inventory normalizations for Primed SmartSide and ExpertFinish suggest prior channel distortions are behind the company, with order intake recovering toward historical levels.
Management expects Siding volume and revenue growth to resume in Q3, supported by capacity expansions, but underlying housing market conditions remain subdued with no assumed near-term market improvements.

Lumen Technologies, Inc.

LUMN Q2 2026

Reported: 2026-08-07

Lumen’s shares dropped 5.7% following earnings as the cautious outlook and ongoing margin pressures overshadowed progress in strategic initiatives like Alkira integration and NaaS growth.

Key takeaways

The company signaled a cautious outlook, reflecting investor concerns about decelerating growth and margin compression, despite claims of strategic progress.
Alkira integration is underway, aiming to simplify multi-cloud networking and enable higher-margin digital services, but these benefits remain largely future potential.
NaaS adoption showed solid growth, with total customers exceeding 3,000, new customer adoption up 22% sequentially, and active ports and services increasing 34% and 29%, respectively.
The decision to phase out certain legacy enterprise voice and communications products underscores a disciplined portfolio pruning toward higher-growth, higher-margin offerings.
Despite operational initiatives, traditional telecom economics in core segments continue to weigh on profitability and investor sentiment.

Medline Inc.

MDLN Q2 2026

Reported: 2026-08-07

Medline’s shares dropped 17.9% following an outlook moderation driven by operational headwinds including the Tracy warehouse fire, quality remediation costs, and softness in the retail segment, which overshadowed strong sales growth and new customer wins.

Key takeaways

Reported 12% top-line growth in Q2, with Medline Brand up 7% and Supply Chain Solutions rising 16%.
Adjusted EBITDA increased 13% to $1.1 billion but was pressured by higher costs, operational expenses, and net tariff impacts.
Headwinds such as the Tracy distribution center fire, Middle East conflict, growth investments, and quality remediation efforts led to a cautious full-year EBITDA outlook.
Customer signings exceeded $650 million, pacing ahead toward the $1 billion annual goal.
Retail business showed softness, contributing to the overall cautious outlook and margin pressures.

Ramaco Resources, Inc.

METC Q2 2026

Reported: 2026-08-07

Ramaco Resources’ stock declined modestly by 0.5% following its Q2 report as investors remained cautious despite progress on the transformative Brook Mine project, reflecting persistent uncertainties around the large refinery capital costs and project timeline.

Key takeaways

The Hatch conceptual study finalized recently confirmed refined processing methods and outlined a large-scale midstream refinery as Ramaco’s most significant and costly project to date.
Project NPV estimates range from $3.4 billion to $8 billion with average adjusted EBITDA between $600 million and $1.3 billion, both considerably higher than previous studies but accompanied by increased capital expenditure and extended timelines.
About 75% of projected revenue will come from critical minerals driven primarily by semiconductor industry demand, shifting away from overreliance on scandium.
Major capital spending for the refinery remains more than two years away, with financing discussions ongoing and contingent on offtake agreements and government support.
The company plans key technical and pre-feasibility reports through 2026 and early 2027, underscoring a deliberate approach to de-risking the project before scaling production.

The Mosaic Company

MOS Q2 2026

Reported: 2026-08-07

Shares rose 3.3% following the quarter as Mosaic's proactive cost management, successful sulfur supply agreements, and sustained potash demand partially offset ongoing headwinds from elevated sulfur prices and production curtailments in phosphate. The market appears to acknowledge the company’s navigating of near-term challenges while maintaining strategic flexibility.

Key takeaways

Phosphate production was curtailed due to high sulfur costs and supply disruptions, with 1.4 million tonnes produced and sold despite market turmoil.
Mosaic secured a significant portion of third-quarter sulfur supply at prices well below current spot levels, improving input cost visibility.
Potash markets remain balanced with strong demand globally, contributing steady earnings and cash flow; summer fill programs were fully subscribed.
SG&A expenses were reduced sustainably, reflecting aggressive cost management that supports margin preservation amid volatile conditions.
The company maintains strong liquidity with access to a $2.5 billion revolver and has refinanced short-term debt to enhance financial flexibility.

MPLX LP

MPLX Q2 2026

Reported: 2026-08-07

MPLX’s shares rose modestly by 0.6% post-earnings, reflecting a quarter that delivered steady operational progress and a stable outlook, but without a clear catalyst to move the stock meaningfully higher.

Key takeaways

Adjusted EBITDA grew 5% year-over-year to $1.8 billion, overcoming the impact of the Rockies asset divestiture in late 2025.
Processing utilization remained strong with 96% in Marcellus and 86% in the Delaware Basin; the new Harmon Creek III plant began operations in August, expanding processing capacity.
Capital spending guidance was increased by $500 million to $2.9 billion, primarily due to accelerated Gulf Coast fractionation project execution.
Mid-single-digit adjusted EBITDA growth is expected for 2026, weighted toward the back half, supported by multiple projects coming into service in the second half.
Operational highlights included volume growth across gathering and processing segments, driven by production increases in Utica, Permian, and Marcellus basins, partially offset by the Rockies divestiture.

Marqeta Inc. Class A Common Stock

MQ Q2 2026

Reported: 2026-08-07

Shares dropped 6.7% as Marqeta's cautious outlook and signs of margin pressures overshadowed solid top-line growth, raising investor concerns about sustained profitability and future momentum.

Key takeaways

Total Payment Volume (TPV) grew 32% year-over-year to $120 billion, maintaining over 30% growth for the fourth consecutive quarter.
Gross profit increased 17%, supported by strong volume gains but potentially signaling margin pressure amid broader business investments.
Adjusted EBITDA rose 31%, reaching a 21% margin, though investors appear wary of margin compression risks going forward.
The company reported $8 million in GAAP net income, marking the second consecutive quarter of profitability, yet investors remain cautious on durability.
Management highlighted expanding multinational card issuing capabilities and new stablecoin-backed card offerings, but the cautious guidance and outlook tempered enthusiasm.

Motorola Solutions, Inc.

MSI Q2 2026

Reported: 2026-08-07

Shares gained 7.0% following a quarter that beat expectations on multiple fronts, driven by broad-based revenue growth, margin expansion, and robust backlog that underpin raised full-year guidance.

Key takeaways

Revenue increased 13%, led by 15% growth in Products and Systems Integration and 10% growth in Software and Services, with strength across all three major technologies.
Non-GAAP operating margin expanded 330 basis points to 32.9%, excluding tariff refund benefits margin still expanded 140 basis points amid higher material costs.
Non-GAAP EPS rose 24% year-over-year to $4.41, supported by strong earnings and a $0.25 per share benefit from IEEPA tariff refunds.
Operating cash flow rose $197 million to $469 million; free cash flow increased $190 million to $414 million despite higher inventory investments.
Ending backlog reached a record $15.6 billion, up 11% versus last year, signaling sustained demand momentum headed into the second half.

NICE Ltd.

NICE Q2 2026

Reported: 2026-08-07

NICE's shares fell 6.0% after the company delivered solid revenue growth but tempered future expectations, signaling investor disappointment with cautious guidance and signs of deceleration in margin expansion and key growth segments.

Key takeaways

Q2 revenue reached $782 million, coming in at the high end of guidance, with cloud revenue growing 12.6% year-over-year.
AI backlog grew an impressive 72% year-over-year, though the company excluded a recent large HMRC deal from these figures, which would have otherwise smoothed growth comparisons.
Non-GAAP EPS of $2.70 matched the high end of the outlook, but investors appeared skeptical given the cautious tone on future scaling and customer adoption timelines.
Despite healthy demand drivers, the narrative hinted at AI adoption moving slower than ideal as customers focus on data preparation, governance, and operating model adjustments before full-scale deployment.
International revenue increased 22%, supported by cloud migration trends and sovereign cloud demand, yet margins and near-term expansion appear challenged amid increased investments.

EnPro Industries, Inc.

NPO Q2 2026

Reported: 2026-08-07

Shares declined 1.7% following Enpro’s Q2 report as solid top-line growth and margin stability were offset by persistent softness in commercial vehicle end markets and a cautious outlook on near-term recovery timing.

Key takeaways

Total sales rose 17.6% year-over-year, led by a 21.8% increase in Advanced Surface Technologies (AST) driven by semiconductor market demand.
Sealing Technologies revenue grew 15.3%, with 5% organic growth supported by acquisitions AlpHa and Overlook, but commercial vehicle markets remained soft with only early signs of stabilization.
Adjusted EBITDA grew 22% to $86.9 million, maintaining a strong margin of 25.6%; Sealing Technologies segment margin held at 33.2% with good pricing discipline and volume gains.
Semiconductor demand outlook remains positive with extended visibility into 2027 and ongoing investment in capacity and innovation.
Despite operational strengths, investor concerns persist around weakness in smaller industrial end markets and the slow recovery in commercial vehicles temper near-term confidence.

Nutrien Ltd.

NTR.TO Q2 2026

Reported: 2026-08-07

Nutrien's shares declined modestly (-0.6%) as investors digested a mixed quarter featuring raised potash volume guidance but ongoing margin pressure in nitrogen and cautious outlook commentary on global urea prices amid geopolitical uncertainty.

Key takeaways

Q2 adjusted EBITDA reached $2.4 billion, with first half EBITDA up 6% year-over-year; cash flow from operations grew 12% in H1.
Potash volumes hit record levels, with the company raising the bottom end of 2026 potash sales guidance and maintaining a controllable cash cost target below $60/tonne.
Proprietary Products margins expanded 10% despite softer overall fertilizer demand, supported by targeted capacity investments and a nearly tenfold increase in select nutritional product sales volumes.
Nitrogen segment faced headwinds from seasonal urea price declines and geopolitical factors, though North American assets benefit from low-cost natural gas and recent operational improvements.
Portfolio optimization progressed with $90 million of non-core asset sales agreements signed and ongoing strategic reviews of phosphate, Trinidad nitrogen, and Brazilian retail businesses.

Realty Income Corporation

O Q2 2026

Reported: 2026-08-07

Shares of Realty Income declined 0.9% following Q2 results, reflecting modest investor caution despite steady AFFO growth and an increased investment guidance. The market appears hesitant on margin pressure and the company’s cautious tone on some international markets. The modest share price decline suggests that while growth and deployment remain solid, investors are digesting margin pressures and cautious international signals without strong upside catalysts.

Key takeaways

AFFO per share increased 3.8% to $1.09 in Q2, with year-to-date growth of 5.2% to $2.22, supporting a $0.02 raise in full-year AFFO midpoint guidance to $4.44-$4.45 (~4% growth).
Total global investments reached $2.6 billion ($2.1 billion pro rata) at an initial weighted average cash yield of 7.3%, with U.S. investments accounting for $1.7 billion at 7.4% yield, heavily weighted to industrial assets (~75% of U.S. investments).
The U.S. Core Plus fund fully deployed remaining cornerstone commitments, lifting gross asset value to ~$3 billion, acquiring assets at a 6% cash yield supported by higher contractual escalators and strong credit tenants.
Europe investments totaled ~$400 million at a 7% yield, but increased client caution due to geopolitical uncertainties may be tempering activity, despite management’s constructive long-term view.
The $6 billion hyperscale data center joint venture with Cloud Capital (Realty Income’s 45% equity stake) is progressing, targeting key supply-constrained digital infrastructure markets driven by AI and cloud demand.

Oportun Financial Corporation

OPRT Q2 2026

Reported: 2026-08-07

Oportun’s Q2 results drove a 33.9% stock surge, led by better-than-expected revenue, improved credit quality, and significant EBITDA growth, signaling execution progress and investor confidence in the company’s stabilization and disciplined growth strategy.

Key takeaways

Total revenue reached $233 million, $1 million above the high end of guidance, supported by modest year-over-year originations growth.
Adjusted EBITDA of $49 million represented 56% year-over-year growth and exceeded guidance expectations.
Annualized net charge-off rate improved by 65 basis points sequentially to 12%, outperforming the upper range of guidance.
GAAP EPS of $0.17 grew 21% year-over-year; adjusted EPS grew 35% to $0.42, reflecting improved profitability.
Company increased unrestricted cash to $140 million and maintained disciplined expense management, supporting financial flexibility.

One Stop Systems, Inc.

OSS Q2 2026

Reported: 2026-08-07

Shares declined 6.7% following the earnings release as investors reacted negatively to margin pressure and a cautious outlook implied by the company’s higher proportion of early-stage, lower-margin programs despite strong bookings and revenue growth.

Key takeaways

Revenue rose 62.3% year-over-year to $9.3 million, driven by growth in both defense and commercial segments.
Customer-funded development revenue increased 145% y/y to $944,000, signaling a shift toward more early-stage, lower-margin work.
Bookings hit a record $15 million in Q2, pushing the year-to-date total to over $30 million with a 1.7 book-to-bill ratio.
Significant contract wins include an $8.4 million defense order and multiple commercial wins expected to generate multi-year revenue streams.
The increased mix of early prototype and low-rate production programs is weighing on gross margins and suggests cautious execution risk ahead.

PACS Group, Inc.

PACS Q2 2026

Reported: 2026-08-07

PACS Group’s Q2 results beat expectations, driving a 4.2% stock increase as revenue growth and margin expansion underscored the strength of their mature facility portfolio and operational execution.

Key takeaways

Revenue rose 9.1% year-over-year, reflecting solid growth across the portfolio.
Adjusted EBITDA expanded 25%, indicating meaningful margin improvement as facilities mature and occupancy rates climb.
Same-store revenue advanced 5.8%, with same-store occupancy up 150 basis points and total occupancy increasing 180 basis points.
Skilled nursing mix improved by 100 basis points compared to the prior year, supporting a higher-margin patient base.
Quality metrics strengthened, with 83.6% of skilled nursing facilities rated 4- or 5-stars by CMS, well above the industry average.

Insulet Corporation

PODD Q2 2026

Reported: 2026-08-07

Shares fell sharply by 16.5% as investors reacted negatively to the unexpected deceleration in type 2 diabetes customer retention and the need for increased investment in customer support, signaling concerns about the sustainability of growth in this key segment.

Key takeaways

Total company revenue grew 23% year-over-year on a constant currency basis, driven by strong demand and favorable price mix.
Adjusted operating margin improved by 140 basis points, reflecting better manufacturing productivity and scale benefits.
Adjusted EPS increased approximately 42%, supported by revenue growth and cost discipline.
New global customer starts reached the second highest quarter ever, with strong U.S. MDI user conversions and international expansion in Spain.
Retention and utilization among type 2 diabetes customers weakened more than anticipated, prompting a strategic shift to expand customer care, modify sales incentives, and refine sampling programs to address lower engagement and retention risks.

PROCEPT BioRobotics Corporation Common Stock

PRCT Q2 2026

Reported: 2026-08-07

Shares rose 5.2% post-earnings, reflecting market approval of stronger-than-expected system demand, notably robust HYDROS placements, and disciplined pricing that drove higher average selling prices.

Key takeaways

Total revenue reached $94.5 million, up 19% year-over-year.
Procedure volume grew 21% to over 13,100 U.S. procedures; however, growth was softer than anticipated, driven by weaker legacy AQUABEAM account performance.
HYDROS system placements were strong with 65 units placed, including 50 new installs and 14 replacements, underscoring successful rollout efforts.
HYDROS average selling price increased to approximately $495,000, up from $485,000 in Q1 and $435,000 in full-year 2025.
Strategic commercial initiatives such as salesforce realignment, replacement upgrades, and patient activation pilots are underway to support sustainable growth.

Pursuit Attractions and Hospitality, Inc.

PRSU Q2 2026

Reported: 2026-08-07

Shares of Pursuit fell 7.6% following the earnings release, reflecting investor disappointment primarily driven by cautious forward guidance and concerns about margin sustainability despite reported revenue growth and strategic transactions.

Key takeaways

Revenue grew 14% year over year, supported by strong contributions from Tabacon and existing markets.
Completed acquisition of Eagle Wing Tours and sale of noncore Flyover business, enhancing portfolio focus and financial flexibility.
Increased full-year adjusted EBITDA growth guidance to 14% at the midpoint, incorporating recent acquisitions.
Management highlighted a sharpened strategic focus and a strengthened balance sheet post-Flyover sale.
Despite positive growth indicators, cautious tone around sustainable margin expansion and future outlook appears to have weighed on sentiment.

Paramount Skydance Corporation Class B Common Stock

PSKY Q2 2026

Reported: 2026-08-07

Paramount's shares rose 6.6% following better-than-expected subscriber growth and margin expansion in its streaming business, which drove investor confidence despite ongoing costs tied to the Warner Bros. Discovery merger.

Key takeaways

Paramount+ subscriber base grew to nearly 82 million, with the best retention quarter on record and double-digit growth in view hours.
Streaming margins expanded in the first half of the year, signaling operational leverage as subscriber scale increases.
Studios business showed improved profitability and an active content pipeline with over 90 series in production.
TV Media profit grew 14% despite revenue declines linked to industry shifts away from linear TV.
Incremental costs related to Warner Bros. Discovery deal include monthly bridge fees of $8–9 million and potential ticking fees of $650 million per quarter if closing is delayed beyond September 30, but financing and liquidity remain solid.

Arcus Biosciences, Inc.

RCUS Q2 2026

Reported: 2026-08-07

Arcus shares declined 1.6% following the Q2 report as investors digested moderate progress in clinical development without new catalysts or positive updates on near-term financial outlook; the cautious tone on timing and upcoming milestones likely tempered enthusiasm.

Key takeaways

Casdatifan remains the centerpiece, with ongoing Phase III trials (PEAK-1 enrolling through year-end) targeting second-line clear cell RCC.
Management emphasized multiple collaborations with bispecific anti-PD-1/VEGF antibodies, expanding options in frontline settings but without definitive efficacy data yet.
The failure of Merck’s competitor LITESPARK-012 provides a clearer path for casdatifan but no immediate impact on Arcus’s financials or patient uptake.
Plans to start a frontline registrational Phase III trial (PEAK-20) remain on track for late 2026, maintaining development timelines but offering no acceleration.
No updated financial guidance or margin commentary was provided to suggest a near-term catalyst or relief from pipeline-related uncertainties.

Rigel Pharmaceuticals, Inc.

RIGL Q2 2026

Reported: 2026-08-07

Rigel’s shares gained 8.1% following Q2 results, driven primarily by the successful in-license and upcoming launch of VEPPANU, which expands the company’s commercial oncology portfolio and opens up a sizable new market opportunity beyond existing products.

Key takeaways

Q2 U.S. net product sales reached $67 million, up 14% year-over-year, led by an 18% rise in TAVALISSE sales to a record $47.4 million.
REZLIDHIA sales grew 27% to $8.9 million, supported by encouraging data on frontline use of VENCLEXTA enhancing REZLIDHIA’s adoption post-VENCLEXTA treatment.
Collaboration revenues, including regulatory milestones for elacestrant and global launches of TAVALISSE, contributed $11.7 million.
The in-licensing of VEPPANU, the first FDA-approved PROTAC for specific breast cancer patients, positions the company for new growth with commercial launch expected mid-August.
Management emphasized a strategic focus on diversifying the commercial portfolio, advancing pipeline candidates like R289, and financial discipline to sustain long-term growth.

Root, Inc.

ROOT Q2 2026

Reported: 2026-08-07

Root’s shares tumbled 14.6% following earnings as investors reacted negatively to cautious growth commentary and a deceleration in key growth metrics despite modest revenue gains.

Key takeaways

Revenue increased a modest 2% year-over-year to $389 million, reflecting slowing top-line momentum amid heightened competition.
Policies in force grew 6% year-over-year to 484,000, indicating continued growth but at a restrained pace.
Net income rose 15% year-over-year to $25 million with a 92.1% net combined ratio, showing underwriting discipline but limited margin expansion.
Management highlighted ongoing competitive pressures driving cautious growth and disciplined marketing spend, potentially constraining near-term expansion.
The company emphasized investments in AI-driven underwriting and pricing models, positioning for longer-term efficiency gains but without concrete near-term guidance upside.

Royalty Pharma plc

RPRX Q2 2026

Reported: 2026-08-07

Royalty Pharma’s shares declined modestly by 0.4% following Q2 results that showed steady growth but did not provide material upside to offset cautious market sentiment. While guidance was raised for 2026, the market reaction suggests underlying concerns about deceleration or limited margin expansion.

Key takeaways

Portfolio receipts increased 6% and total receipts grew 14% year-over-year, reflecting steady, predictable cash flow growth.
Return on invested capital was 14.2%, with return on equity at 20.1%, indicating attractive, though not improving, returns.
The company deployed $1.1 billion on royalty acquisitions in H1 2026, including a significant deal on AstraZeneca’s cliramitug with potential blockbuster upside.
Guidance for full-year 2026 was raised for the second quarter in a row, reflecting confidence in the portfolio’s momentum but no dramatic acceleration.
Key pipeline updates highlighted progress on clinical development and regulatory approvals, but no new transformative milestones announced this quarter.

Recursion Pharmaceuticals, Inc.

RXRX Q2 2026

Reported: 2026-08-07

Shares declined 3.9% as investors responded negatively to cautious outlook signals and the lack of concrete near-term commercialization catalysts despite ongoing pipeline and partnership progress.

Key takeaways

The company advanced five clinical-stage programs, including REC-4881 with promising Phase II data in a $10 billion FAP market lacking approved therapies.
Partnership milestones included over $500 million in inflows and a new early discovery neuroscience program with Roche-Genentech, signaling validation of the AI platform but still at an early stage.
REC-4881 expects additional Phase II data and FDA updates later this year; REC-1245 dose escalation and REC-7735 IND clearance position these assets for further clinical progress.
Anticipated milestones include Sanofi candidate nomination and Phase I initiation for REC-7735, supporting pipeline depth but with no immediate revenue impact.
Emphasis on scaling proprietary multimodal data and continuous model improvement underscores long-term ambitions, but tangible near-term growth drivers remain limited.

Satellogic Inc. Class A Ordinary Shares

SATL Q2 2026

Reported: 2026-08-07

Satellogic’s Q2 results impressed investors as revenue surged 259% year-over-year and the company achieved positive adjusted EBITDA for the first time, driving a +12.2% stock reaction. The market rewarded clear signs of operating leverage and growing sovereign defense contracts that provide strong revenue visibility.

Key takeaways

Revenue grew 259% year-over-year to $15.9 million in Q2, driven by sovereign satellite deliveries and expanding Data & Analytics subscriptions.
Gross margin stood at a healthy 82% (excluding depreciation), underscoring cost efficiency amid rapid growth.
Operating expenses rose only 46% versus revenue growth of 259%, enabling positive operating income (~$300,000) and positive adjusted EBITDA of $2.8 million for the quarter, both company firsts.
Contracted backlog totaled $80.7 million with $45.8 million expected within 12 months, supporting near-term revenue visibility.
Despite a GAAP net loss of $20 million due to significant noncash charges, adjusted operating cash flow was near breakeven for the first half, reflecting improving financial health.

Schrodinger, Inc.

SDGR Q2 2026

Reported: 2026-08-07

Shares jumped 13.8% after Schrodinger reported better-than-expected ACV growth and strong commercial momentum, driven by broad-based demand and early adoption of new AI-enabled products.

Key takeaways

ACV grew 27% year-over-year to $29.6 million in Q2, with non-contribution ACV up 23%, hitting the high end of guidance.
Notable customer traction includes large pharma, biotech, and materials science sectors, underpinning broad demand.
Launch of Bunsen, an AI co-scientist, started in early access last week, expected to drive significant platform usage growth via a throughput-based licensing model.
Bristol Myers Squibb expanded its partnership, adopting Bunsen widely, exemplifying large-scale platform deployment.
Contribution ACV totaled $7 million, including extended funding from the Gates Foundation supporting predictive toxicology and battery research initiatives.

Safilo Group S.p.A.

SFL.MI Q2 2026

Reported: 2026-08-07

Safilo’s shares rose 5.3% following the earnings release, reflecting investor appreciation for the company’s margin expansion and strong cash generation despite a notable sales decline in a softer demand environment.

Key takeaways

Net sales declined 1.9% in the first half, with a sharper 4.5% drop in Q2, reflecting cautious ordering and weaker demand across core markets.
Margin expansion continued, driven by structural improvements and a one-time tariff refund of EUR 20 million recognized in the P&L.
Cash flow remained robust, enabling full funding of strategic acquisitions (SPY+ and Serengeti) and initiation of a new share buyback program.
Geographic performance was mixed: Europe slightly down (-0.5% H1), North America modestly weaker (-0.8% H1), and Asia Pacific notably soft (-17.7% Q2) due to difficult comps and event timing shifts.
Premium and luxury brands (e.g., Carrera, Smith, Kate Spade) showed relative resilience amid broad-based market softness.

Super Group (SGHC) Limited

SGHC Q2 2026

Reported: 2026-08-07

Shares fell 6.7% as investors reacted negatively to a cautious outlook signaled by a softer-than-expected customer engagement trajectory, highlighted by a sequential decline in monthly active users (MAUs) despite World Cup-driven revenue growth and raised full-year guidance.

Key takeaways

Revenue rose 18% year-over-year to a record $684 million, driven notably by a 36% increase in African markets and strong World Cup-related wagering.
Adjusted EBITDA grew 30% to $204 million, with margin expansion to 30%, aided by improved sports margins and disciplined cost management.
Average monthly active customers increased 13% year-over-year to 6.2 million but showed a sequential decline and a 2% year-over-year decrease in marketing spend, raising concerns about sustained engagement.
The U.K. segment experienced margin pressure from tax impacts and elevated short-term promotional costs, offsetting some underlying growth.
Despite a raised full-year revenue and EBITDA guidance, investor skepticism over the quality and durability of customer metrics and marketing strategy likely pressured shares.

Sprott Inc.

SII.TO Q2 2026

Reported: 2026-08-07

The 6.9% stock gain reflects investor relief that net inflows into critical materials ETFs and strong execution on new launches helped offset a sharper-than-expected pullback in precious metals-related assets and AUM declines.

Key takeaways

Total AUM declined to $55.6 billion, down 15% from the prior quarter, primarily driven by a 16% drop in AUM in precious metals physical trusts amid significant commodity volatility.
Despite the AUM drop, average AUM for the quarter was $63.9 billion, up 70% year-over-year, supported by net inflows and prior market appreciation.
Net income rose to $34.3 million for the quarter, up from $13.5 million a year ago, aided by higher average AUM and carried interest crystallization in private strategies.
Critical materials ETFs showed resilience, generating net inflows and positive sales, with copper and uranium markets supporting investor interest.
The company continued share repurchases, maintaining a strong cash and liquidity position despite market headwinds.

SiTime Corporation

SITM Q2 2026

Reported: 2026-08-07

SiTime’s stock surged nearly 18% on exceptionally strong second-quarter results driven by robust revenue growth, expanding margins, and significant outperformance in its communications, enterprise, and data center segment.

Key takeaways

Revenue soared 127% year over year to $157 million, reflecting broad-based demand across all business units and regions.
Gross margin expanded 8.9 percentage points to 67.1%, with operating margin improving sharply to 34% from 10% a year ago.
Net income rose 400% to $65.7 million, or $2.34 per diluted share, underscoring significant profitability gains.
Communications, enterprise, and data center (CED) business grew 181% and surpassed $100 million in quarterly revenue, marking the ninth consecutive quarter of triple-digit growth.
Strong indicators of future demand include increased book-to-bill ratio, larger order sizes, advanced product mix driving higher ASPs, and order visibility now extending 12 to 18 months into 2027.

Skyward Specialty Insurance Group Inc. Common Stock

SKWD Q2 2026

Reported: 2026-08-07

Skyward Specialty shares rose 6.6% following strong premium growth and improved underwriting profitability that outpaced market expectations, supported by disciplined expense management and a robust capital position.

Key takeaways

Diluted Operating EPS increased 46% year-over-year to $1.30, driven by strong underwriting results and premium growth.
Gross Written Premiums rose 13% to $741 million, led by 14% growth in Skyward Specialty and 6% at Apollo, with Managed Premiums up 18%.
Skyward Specialty's Combined Ratio improved to 86.9 (Ex-CAT 85.6), despite slight pressure on non-cat loss ratios due to business mix shifts toward higher loss ratio lines (Accident & Health, Global Agriculture).
Expense discipline and AI-driven efficiency reduced the Expense Ratio by 2.7 points to 24.3, contributing to profitability gains.
Balance sheet remains strong with equity near $1.3 billion, financial leverage falling to 26%, and an increase in share repurchase authorization to $100 million signaling confidence in valuation and capital allocation.

SLR Investment Corp.

SLRC Q2 2026

Reported: 2026-08-07

SLR Investment Corp’s shares fell 1.9% following Q2 results marked by modest NAV decline driven by two new non-accrual loans, signaling isolated credit pressures despite continued portfolio discipline and durable investment activity.

Key takeaways

Net asset value per share declined by less than 90 basis points to $18.00, primarily due to markdowns on two loans placed on non-accrual during the quarter.
Net investment income (NII) was reported at $0.33 per share, with net income at $0.15 per share for Q2 2026.
Originations reached $471 million, with 90–98% weighted to specialty finance, 60% above the average since 2018, reflecting continued strategic focus.
Portfolio repayments totaled $431 million, resulting in net originations of approximately $40 million and a portfolio size of $3.2 billion at quarter-end.
Watch list remains low at 2.5%, and exposure to the software industry—a sector facing refinancing challenges—is minimal at under 1%.

NuScale Power Corporation

SMR Q2 2026

Reported: 2026-08-07

NuScale’s Q2 results triggered a modestly negative market reaction (-0.2%), reflecting mixed investor sentiment on commercial progress and ongoing execution risks rather than clear positive or negative surprises.

Key takeaways

NuScale emphasized readiness and engineering maturity as differentiators against past nuclear projects, citing substantial supplier partnerships and advanced design completion.
The company reaffirmed progress toward key commercial milestones with ENTRA1 Energy and RoPower, though no definitive power purchase agreements or contracts were finalized this quarter.
Supply chain partnerships with heavy component manufacturers (Doosan), fuel providers (Framatome), and instrumentation contractors (Paragon) continue to develop, intended to shorten lead times and improve execution certainty.
NuScale expanded its Energy Exploration Centers to 12 locations, focusing on workforce training and industry ecosystem development, a long-term investment not yet tied to revenue growth.
The quarter’s narrative lacked updated financial metrics or explicit guidance changes, leaving near-term revenue and margin outlooks uncertain for investors.

SanDisk Corp.

SNDK Q4 2026

Reported: 2026-08-07

Shares fell 11.8% after the quarter, reflecting investor disappointment with the cautious outlook and indications of demand deceleration, particularly in consumer and PC end markets, despite reported record revenue and margins.

Key takeaways

The company delivered record revenue, gross margin, and earnings per share, all above the high end of guidance.
Datacenter exposure grew substantially, now representing 38% of total bit production, up from 12% a year ago, marking it as the fastest-growing segment.
Management highlighted a near-term adjustment in PC and smartphone demand tied to shifts towards AI-enabled premium devices, constraining growth in these markets.
The broader consumer and Edge markets remain strategically important but face ongoing headwinds in the short term before expected growth resumes in calendar year 2027.
Sandisk maintains technology leadership with BiCS 8 NAND volume ramp and is focusing on driving future cost and performance leadership amid pressured demand dynamics.

Solventum Corporation

SOLV Q2 2026

Reported: 2026-08-07

Solventum's shares dropped 5.7% following the quarter, primarily due to modest signs of deceleration in organic growth and cautious comments around the portfolio separation strategy, which raised investor concerns about near-term execution risks despite management’s upbeat narrative.

Key takeaways

The company reported organic growth and EPS ahead of expectations on a non-GAAP basis, with solid top- and bottom-line performance.
Operating margins were reportedly stable or slightly better than expected, helped by disciplined execution amid ongoing transformation and ERP cutovers.
Portfolio optimization plans included advancing the separation of the Health Information Systems (HIS) business, highlighting potential near-term uncertainty despite a promising long-term rationale.
Acera, the recent acquisition, continues to deliver strong growth with year-over-year revenue growth above 40% and gross margins over 80%.
Management emphasized progress on the ERP transition and transformation phases, but the market appears cautious on the practical impact and timeline for unlocking shareholder value.

SoundHound AI Inc Class A Common Stock

SOUN Q2 2026

Reported: 2026-08-07

SoundHound AI’s Q2 revenue and profitability metrics meaningfully outperformed expectations, driven by strong demand for its new OASYS AI platform, sending the stock up 8.8% post-earnings.

Key takeaways

Revenue reached a record $62 million, up 45% year-over-year and 40% sequentially.
Gross margin, adjusted EBITDA, and EPS all improved both year-over-year and sequentially.
The recently launched OASYS self-learning agentic AI platform is gaining rapid traction, enabling faster deal cycles and scaled implementations.
Strong customer wins span multiple verticals, notably health care (including a top 20 provider quadrupling spend) and financial services (renewals and expansions with leading banks and insurers).
Continued disciplined spending delivered a 33% improvement in adjusted EBITDA despite growth investments.

SP

SpaceX CDR (CAD Hedged)

SPCX.TO Q2 2026

Reported: 2026-08-07

SpaceX's Q2 results came in largely as expected, with revenue and adjusted EBITDA showing substantial year-over-year gains, while the stock showed no meaningful reaction, implying investors found no surprises in the report or outlook.

Key takeaways

Revenue rose 92% year-over-year to $7.8 billion, reflecting continued top-line expansion.
Adjusted EBITDA surged 191% to $3.5 billion, indicating improved operational cash flow performance.
Net loss narrowed by $467 million to $541 million, showing progress toward profitability but still a material loss.
Starship achieved two successful V3 flights recently, advancing capabilities critical for future orbital missions.
Starlink’s next-generation V3 satellites offer roughly an order of magnitude greater bandwidth capacity, positioning for significant revenue growth over the next decade.

Sequans Communications S.A.

SQNS Q2 2026

Reported: 2026-08-07

Sequans shares jumped 13.1% following a quarter that delivered better-than-expected revenue growth and strong order momentum, particularly in its IoT semiconductor business. The market rewarded the clear acceleration in product sales and expanding design win pipeline, signaling confidence in the company’s 5G eRedCap development and entry into new defense and drone segments.

Key takeaways

Q2 revenue rose to approximately $7.5 million, surpassing prior guidance and representing a 23% sequential increase.
Product sales grew more than 80% year-over-year, driven by strong performance in CAT M and CAT 1bis technologies.
Design win pipeline expanded beyond $300 million in potential three-year revenue, with 55% (about $165 million) now in mass production—a threefold increase over the prior year.
Secured 10 new design wins in Q2 while transitioning a similar number of projects into production, supporting a healthy backlog through 2027.
Progressing in new markets with RF transceiver shipments for defense and drone applications and targeting 5G eRedCap customer sampling in H2 2027.

SSR Mining Inc.

SSRM.TO Q2 2026

Reported: 2026-08-07

SSR Mining's stock rose 13.3% following Q2 results as the market rewarded the company’s strong cash position, strategic divestments, and resumed growth investing, signaling confidence in its pivot to a free cash flow-focused Americas producer with robust capital returns.

Key takeaways

Q2 production came in at 102k gold equivalent ounces with all-in sustaining costs of $26.22/oz, in line with company expectations.
The company successfully exited Türkiye, receiving approximately $1.5 billion in cash from asset sales, lifting total cash to nearly $1.8 billion and leaving SSR debt-free.
SSR is increasing growth capital expenditures in H2 2026, targeting mine life extensions and operational resilience to support future growth.
The returning of $400 million to shareholders year-to-date implies an 8% yield, with ongoing share buybacks and dividends planned.
Management anticipates stronger second half production with costs trending toward the high end of guidance due to elevated fuel prices and planned capital spending.

System1 Inc. Class A Common Stock

SST Q2 2026

Reported: 2026-08-07

System1's shares fell 17.4% after the earnings release as investors were disappointed by continued margin compression and weak monetization, particularly from Google, which offset healthy user growth across key products.

Key takeaways

Total sessions across owned sites rose 31% year-over-year and 5% sequentially, driven by strong audience growth in search, mapping, and shopping verticals.
CouponFollow showed solid organic session growth (+11% vs Q1) and a 37% year-over-year increase in gross profit from paid traffic acquisition.
MapQuest sessions increased 25% year-over-year in H1 2026, with strong display advertising CPMs maintaining stable ad revenue.
Startpage search engine saw 11% sequential growth in user sessions and a 63% year-over-year increase in mobile app sessions, yet revenue declined due to volatile and reduced Google ad payouts.
Management highlighted the critical need to resolve Google monetization issues, which have limited revenue conversion despite user growth and represent a broader industry challenge.

Sterling Construction Company, Inc.

STRL Q2 2026

Reported: 2026-08-07

Sterling Infrastructure's shares dropped 12.3% following earnings as investors reacted negatively to a cautious outlook and margin pressure implied by the company’s reallocation away from lower-margin Transportation Solutions toward higher-margin but more selective and capital-intensive E-Infrastructure projects, raising concerns about near-term revenue deceleration and increased CapEx.

Key takeaways

Revenue surged 90% year-over-year, driven primarily by 192% growth in E-Infrastructure, but Transportation Solutions revenue declined 20% due to a strategic pivot away from lower-margin projects.
Adjusted EBITDA more than doubled, with margins expanding 150 basis points to 22%, supported by selective project execution in mission-critical E-Infrastructure segments.
Backlog grew substantially: signed backlog up 116% to $4.3 billion and combined backlog rose 150% to $5.6 billion, reflecting strong visibility but with a noted 11% decline in Transportation Solutions backlog versus year-end 2025.
Capital expenditures guidance was increased by $30 million to a range of $130–$140 million for 2026, signaling higher investment needs tied to growth initiatives.
Despite strong headline growth numbers, the accelerated reallocation and winding down of lower-margin business raised concerns about near-term revenue mix shifts and margin sustainability, dampening investor sentiment.

Sysco Corporation

SYY Q4 2026

Reported: 2026-08-07

Sysco’s stock declined 0.9% as the market reacted tepidly despite modest revenue and profit growth, reflecting investor caution on margin expansion and segment softness against improving volumes.

Key takeaways

Total revenue rose 4.7% year-over-year to over $22 billion, driven by case volume growth across local, national, and international segments.
Adjusted EPS for Q4 reached $1.53, surpassing prior guidance, contributing to a full-year adjusted EPS of $4.61, above the full-year guidance range.
USFS local volumes grew 2.6% in Q4, improving sequentially on a two-year stacked basis, aided by AI tools boosting salesforce productivity and customer retention.
National contract case volumes increased 2.6%, supported by healthcare, travel, hospitality, and foodservice management, though offset partially by ongoing softness in national restaurants.
Gross profit growth of 3.7% and adjusted operating profit growth of 4.1% were supported by strategic sourcing and supply chain productivity improvements, but margin gains appear modest relative to revenue growth.

TaskUs Inc. Class A Common Stock

TASK Q2 2026

Reported: 2026-08-07

Shares jumped 19.6% post-earnings, driven by upside on revenue and EBITDA margins against guidance and strong growth outside the largest client despite ongoing headwinds from that key relationship.

Key takeaways

Q2 revenue was $309 million, beating the top end of guidance by $10.9 million (+3.6%) with 5% year-over-year growth.
Adjusted EBITDA margin came in at 18.7%, 70 basis points above guidance, delivering $57.7 million in adjusted EBITDA, 7.5% ahead of expectations on a dollar basis.
Revenue from the largest client fell by approximately 22% year-over-year, impacting total revenue concentration which dropped to 20% from 26% last year.
Excluding the largest client, revenue grew about 15% year-over-year, with the second through twentieth largest clients expanding roughly 30%, showing accelerated momentum versus Q1.
Strong adjusted free cash flow of $36.4 million reduced net leverage below 1.3x, supporting continued investments in AI and growth initiatives.

Triple Flag Precious Metals Corp.

TFPM.TO Q2 2026

Reported: 2026-08-07

The stock surged 7.2% on Triple Flag’s Q2 results, driven primarily by accelerated organic growth and a raised 2026 gold equivalent ounces (GEO) production guidance bolstered by the recent Ravenswood acquisition and resolved Steppe Gold disputes.

Key takeaways

Sold nearly 29,000 GEOs in Q2, contributing to a strong first half with nearly 59,000 GEOs, supporting the raised 2026 guidance of 100,000 to 110,000 GEOs and 2030 outlook to 150,000 to 160,000 GEOs.
Adjusted EBITDA reached $117 million, with operating cash flow per share climbing 42% year-over-year to $0.54, reflecting high-margin leverage to gold and silver prices.
Closed a $440 million acquisition of a 5.5% gold stream on the Ravenswood mine, delivering immediate cash flow from a large-scale, low-cost, long-life asset.
Resolved outstanding disputes with Steppe Gold, receiving arrears and securing fixed gold deliveries over the next decade, adding over 34,000 ounces to the portfolio’s supply.
Maintained strong capital allocation with a 4% increase to an annualized dividend of $0.24 per share and $20 million in opportunistic share buybacks this quarter, supported by robust liquidity of over $1.1 billion despite recent capital deployment.

Tutor Perini Corporation

TPC Q2 2026

Reported: 2026-08-07

Tutor Perini’s shares rose 11.7% post-earnings, reflecting investor approval of the company’s record revenue, substantial operating margin expansion, and robust cash flow generation that outpaced expectations.

Key takeaways

Q2 revenue grew 19% year-over-year to $1.6 billion, driven by early-stage contributions from large projects with significant remaining scope.
Operating income surged 54% to $118 million, supported by strong execution on mega projects.
Segment operating margins improved sequentially across all divisions: Civil at 15.3%, Building at 5.6%, and Specialty Contractors at 2.2%, with further margin gains expected in the second half.
Operating cash flow for the first half reached a record $334 million, underpinned by solid collections from profitable projects.
Backlog remains near record levels at $19.9 billion, bolstered by a $1.7 billion book-to-burn ratio and a sizable pipeline of over $200 billion in potential opportunities within the next several years.

Thomson Reuters Corporation

TRI Q2 2026

Reported: 2026-08-07

Shares declined 8.2% as investors reacted to cautious commentary on near-term growth and margin pressures despite management’s optimistic framing of accelerating revenue growth and innovation. The market appears to have discounted the modest margin outlook and the ongoing structural decline in the Global Print segment, tempering enthusiasm around the broader portfolio shift.

Key takeaways

Total company organic revenue grew 8%, with the "Big 3" divisions accelerating to 10% organic growth, driven primarily by Legal Professionals and Corporates.
Despite reported acceleration, Global Print revenues declined 3% organically, continuing a multi-year downtrend attributed to structural pressures in that business.
Gross margin guidance implies stable margins around 40% despite ongoing heavy investments in AI innovation and portfolio transformation.
The company completed a $600 million share repurchase and a $605 million capital return, reducing share count by 3%, signaling focus on capital allocation amid uncertain growth dynamics.
Market skepticism likely stems from the cautious tone on margin expansion and portfolio pressures, which appear to have outweighed positive signals from product upgrades, AI initiatives, and growth in recurring revenue streams.

Trinity Capital Inc.

TRIN Q2 2026

Reported: 2026-08-07

The stock fell 3.1% following earnings, driven by investor concerns over a cautious interplay between growth opportunities and underwriting discipline, despite solid originations and NAV growth. The market appears to have discounted limited visibility on future deployments, given that 91% of commitments remain contingent on further diligence and approvals.

Key takeaways

Net asset value rose 9% sequentially and 37% year-over-year to $1.3 billion, with NAV per share increasing from $13.27 to $13.47.
Record quarterly fundings of $619 million and commitments of $709 million, but 91% of $1.2 billion unfunded commitments remain subject to ongoing diligence and investment committee approval.
Managed funds contributed 6% of net investment income, with new vehicles like the SBIC fund and Capital Southwest joint venture adding incremental income streams.
Non-accruals improved to less than 1% of the portfolio at fair value, reflecting stable credit quality.
Dividend coverage remained intact with net investment income per share of $0.51 covering the $0.17 monthly dividend, signaling consistent earnings but tempered by cautious pipeline visibility.

Trupanion, Inc.

TRUP Q2 2026

Reported: 2026-08-07

Trupanion’s shares jumped 14.2% following results that demonstrated clear acceleration in pet acquisition and improving unit economics, boosting investor confidence in growth and profitability prospects.

Key takeaways

Net subscription pets added in the quarter increased 39% year-over-year to approximately 18,800, driven by initiatives enhancing the enrollment experience and pet acquisition investments.
Subscription adjusted operating income grew 24% year-over-year, supporting the company’s target of $180 million total adjusted operating income in 2026.
Average monthly revenue per pet rose 9% year-over-year to $87.44, reflecting pricing discipline and product enhancements including expanded deductible and coinsurance options.
Retention remained strong and improved marginally to 98.37% over the trailing 12 months.
The lifetime value of new enrolled pets increased 25%, indicating better alignment of acquisition costs with long-term economics despite a slight decline in value proposition (cost of paying vet invoices) to 70.2%.

TTM Technologies, Inc.

TTMI Q2 2026

Reported: 2026-08-07

TTM Technologies shares rose modestly by 2.7% post-earnings, reflecting solid execution and broad-based demand, though the move suggests investors are digesting strong top-line growth and margin expansion without significant upside surprises.

Key takeaways

Revenue reached a record quarterly high of $1.0 billion, growing 37% year-over-year, fueled primarily by demand in data center and networking end markets tied to AI.
Non-GAAP EPS rose 71% year-over-year to $0.99, also a record, supported by strong margin expansion.
Adjusted EBITDA margin improved by 160 basis points to 16.6% year-on-year, driven largely by favorable sales mix.
Aerospace and defense sales grew 14% year-over-year, comprising 37% of total revenue, with strong operational performance across most facilities.
Management affirmed earlier guidance of $4 billion in full-year sales for 2026 and maintained optimistic organic revenue growth of 15% to 20% for 2027 and 2028.

Uber Technologies, Inc.

UBER Q2 2026

Reported: 2026-08-07

Uber’s stock declined 2.1% following Q2 results that showed continued top-line growth but left investors hesitant amid cautious commentary on the commercialization pace of autonomous vehicles and lack of clear near-term margin expansion drivers.

Key takeaways

Gross bookings grew 22% year-over-year to over $58 billion, sustaining healthy demand across Uber’s platform.
Non-GAAP EPS advanced 35% year-over-year, reflecting significant operating leverage and cost control.
Free cash flow surpassed $10 billion on a trailing 12-month basis for the first time, underscoring strong cash generation.
Management emphasized ambitious autonomous vehicle (AV) expansion plans, targeting live service in 15 cities by year-end and 28 cities by 2028, though current contribution remains small.
The outlook relies heavily on execution of partnerships and progressive market launches in AV and delivery robotics, with uncertain near-term economics and timing for meaningful margin impact.

Upstart Holdings, Inc.

UPST Q2 2026

Reported: 2026-08-07

Upstart’s shares rose modestly by 2.6% following Q2 earnings, reflecting a mixed reception to strong personal loan growth and margin expansion offset by ongoing investments and structured but cautious progress in secured products.

Key takeaways

Core personal loan originations reaccelerated 27% quarter-over-quarter, contributing $526 million of new volume and driving unsecured contribution margin up 6 percentage points.
Secured products (Home and Auto) grew originations 45% sequentially and improved contribution margin by 61 percentage points, moving closer to breakeven but still investing heavily ahead of profit generation.
Total originations across all products increased 23% sequentially, totaling a $782 million lift compared to Q1.
Loans held on balance sheet declined to 5.9% of total outstanding loans, the lowest level in nearly two years, reflecting effective capital management.
The company returned to GAAP profitability and posted record contribution profit, though operating expenses reflect early-stage investment in secured verticals.

Viper Energy Partners LP

VNOM Q2 2026

Reported: 2026-08-07

Shares declined 5.2% as investors reacted negatively to the removal of the previous quarterly commitment to return at least 75% of available cash to shareholders, signaling concerns over reduced cash flow visibility and variability in returns despite an increased base dividend.

Key takeaways

Third quarter production guidance implies ~4.5% growth sequentially and a 15% annualized growth rate per share relative to Q4 2025.
Announced a 32% increase to the base dividend, raising the annualized rate to $2 per Class A share, implying a ~4.5% yield at current prices.
Removed prior commitment to return at least 75% of available cash flow quarterly; now favoring a higher base dividend plus flexible allocation of excess cash toward buybacks, debt reduction, or acquisitions.
Management highlighted the durability of the base dividend, protected down to $30/bbl WTI, citing a low dividend breakeven relative to the sector.
Market appears unconvinced by the revised capital return framework, potentially discounting the loss of predictable variable distributions despite steady organic and inorganic production growth.

Viasat, Inc.

VSAT Q1 2027

Reported: 2026-08-07

Viasat’s shares declined modestly by 0.3% following the first quarter fiscal 2027 earnings release, reflecting investor caution despite record backlog in Defense and steady cash flow, as lingering competitive pressures and mixed portfolio performance temper enthusiasm.

Key takeaways

Defense and Advanced Technology (DAT) segment secured record new awards and backlog, including the next phase of the Protected Tactical SATCOM-Global (PTS-G) program.
Government SATCOM services revenue grew 10% year-over-year, driven by integrated multi-orbit and dual-use satellite solutions.
Free cash flow increased 19% to $72 million, supported by operating cash flow of $291 million.
Ongoing headwinds in certain portfolio segments impacted overall results, highlighting increased competition in parts of the market.
Operational priorities include leveraging new technology to reduce airtime costs, integrating AI and machine learning for network optimization, and focusing on mobile satellite service frequency bands, particularly direct-to-device capabilities.

Western Digital Corporation

WDC Q4 2026

Reported: 2026-08-07

Western Digital's stock dropped 17.7% on disappointing guidance and cautionary outlook despite management’s positive narrative on AI-driven storage demand. The steep selloff signals investor skepticism around near-term growth prospects and margin sustainability.

Key takeaways

Despite a 36% year-over-year revenue increase, investors were unsettled by cautious forward commentary and implied slower momentum in key segments.
Management emphasized secular demand growth driven by AI and Agentic AI workloads, but the market appears unconvinced this will translate into near-term earnings upside.
Upcoming product launches (44TB HAMR drives, 40TB ePMR, UltraSMR) are progressing, yet visibility and ramp timing seem less certain.
Margins expanded last year, but there was little clarity on sustaining this margin profile amid evolving customer dynamics.
Free cash flow generation of $3.5 billion and balance sheet strength were overshadowed by concerns about growth deceleration and a guarded outlook for fiscal year 2027.

Essential Utilities, Inc.

WTRG Q2 2026

Reported: 2026-08-07

The stock rose modestly by 0.8% following the earnings release, reflecting a largely in-line quarter with steady capital investment, supportive regulatory progress, and a maintained earnings growth outlook, though margin pressures and expense growth temper enthusiasm.

Key takeaways

Reported GAAP EPS was $0.37, slightly impacted by $0.01 in merger-related costs; non-GAAP EPS stood at $0.38.
Earnings benefited from a $0.06 boost in regulatory recoveries, $0.02 from higher water volumes, and $0.01 from water customer growth.
Offsets included $0.02 from lower gas volumes, a $0.02 increase in operating expenses, and a $0.06 combined drag from higher depreciation, interest expense, and lower AFUDC.
Operating expenses rose $5.1 million (3.5%), driven mainly by $5.9 million in employee costs and production increases, partially offset by reductions in insurance, bad debt, and customer assistance surcharges.
Merger regulatory approvals continue steadily with expectations to close in early 2027; dividend was raised by 5.25%, maintaining a strong payout track record.

TeraWulf Inc. Common Stock

WULF Q2 2026

Reported: 2026-08-07

TeraWulf’s shares fell 6.7% post-earnings as investors reacted negatively to cautious outlook signals and potential margin pressure, despite ongoing execution and expansion efforts. The market appears concerned about deceleration risks and selective asset monetization diminishing future growth optionality.

Key takeaways

Delivered full operations of CB-3 at Lake Mariner, adding 102 megawatts of revenue-generating compute capacity and triggering $600 million in Google credit support.
Advanced construction and commissioning at CB-4 and CB-5, with early data hall energizing expected in late September and early January, respectively.
Expanded presence in Kentucky via a 401-megawatt long-term lease with Anthropic, securing approximately $19 billion in contracted revenue over 20 years.
Acquired the Muskie site in Eastern Kentucky, a gigawatt-scale, utility-supported data campus with initial power service anticipated by Q4 2028.
Monetized the Abernathy joint venture with a $530 million sale agreement, signaling a more cautious capital allocation approach focused on sites with greater control and visibility.

Wynn Resorts, Limited

WYNN Q2 2026

Reported: 2026-08-07

Wynn Resorts shares edged up 2.8% post-earnings, reflecting a generally steady quarter across most segments despite notable cost pressures and project delays weighing on near-term margins and timelines.

Key takeaways

Wynn Las Vegas EBITDAR reached $215 million with a 33.5% margin, although slight unfavorable hold shaved $3.6 million; operating expenses rose 6.2% year-over-year due to increased volumes and ongoing investments in premium experiences.
Encore Boston Harbor posted $56 million of EBITDAR on $209 million revenue, maintaining disciplined cost control as OpEx per day increased just 2.9% amid labor headwinds; margin at 26.8%.
Macau delivered $297 million EBITDAR on $1 billion revenue, with VIP hold shortfall costing about $8.6 million; OpEx per day increased 9% year-over-year driven by premium customer investments and inflation.
Wynn Al Marjan Island project faces a $600 million budget increase and a revised opening delayed to September 2027, attributed partly to regional conflict-related disruptions impacting supply chains and costs.
Construction approved on Macau’s Event Center and Theater with completion expected in 2028, underscoring continued capital commitments despite near-term challenges.

Block, Inc.

XYZ Q2 2026

Reported: 2026-08-07

Shares declined 6.6% as investors appeared disappointed despite management’s positive tone, likely due to cautious outlook signals and concerns about decelerating user growth in key segments.

Key takeaways

Gross profit grew 25% year-over-year with adjusted operating income margin reaching 27%, but monthly transacting actives on Cash App only increased 3% year-over-year, signaling slowing customer growth.
Square segment saw 13% year-over-year gross profit and GPV growth, with acceleration in U.S. GPV growth, yet the market reaction suggests investors found this insufficient.
Cash App Consumer Lending origination volume grew 59%, but overall cautious guidance around low single-digit actives growth into 2026 may have raised concerns.
Management announced increased investments in AI and go-to-market channels, which might pressure margins or signal slower near-term profitability expansion despite record profitability this quarter.
Raised full-year guidance reflects confidence but did not prevent negative market reaction, implying investors expected stronger or more aggressive growth outlooks.

Clear Secure, Inc.

YOU Q2 2026

Reported: 2026-08-07

CLEAR’s shares fell 4.9% following the earnings release, driven by investor concerns over cautious outlook and potential margin pressure despite solid bookings growth.

Key takeaways

Bookings reached $296 million, up 33% year-over-year, demonstrating sustained top-line growth.
Free cash flow increased 60% year-over-year to $189 million, highlighting strong cash generation.
Adjusted EBITDA margin surpassed the 35% target at 36.4%, reflecting operating leverage alongside ongoing investments.
Membership base expanded to nearly 44 million total members, supporting long-term growth initiatives.
Management emphasized new product launches and government partnerships but signaled cautious execution amid evolving identity security challenges.

Zalando SE

ZAL.DE Q2 2026

Reported: 2026-08-07

Zalando's shares dropped 16% as investors reacted negatively to the company’s downward revision of its 2026 growth guidance and a cautious outlook despite ongoing investments in AI and platform expansion.

Key takeaways

The company narrowed its 2026 GMV and revenue growth guidance to the lower half of the original 12%-17% range, signaling softer demand mainly in the sneakers category.
Adjusted EBIT guidance was tightened to EUR 680 million–720 million, reflecting margin pressure and moderated profit expectations despite prior double-digit EBIT growth.
Group Q2 revenue and GMV continued to grow (reported GMV +21%, revenue +22% year-on-year), but on a like-for-like basis including ABOUT YOU, GMV growth was only mid-single digits.
AI initiatives are progressing, including AI-generated content through SCAYLE Studios and enhancements to the Zalando Assistant, contributing to operational efficiencies and customer engagement improvements.
The Partner Business showed strength with 13.4% GMV growth in H1, while B2B revenue advanced nearly 26%, driven by enterprise client wins and scaling merchant collaborations.

Zeta Global Holdings Corp.

ZETA Q2 2026

Reported: 2026-08-07

Zeta Global’s Q2 2026 results notably outperformed expectations, driving a 20% stock rally as revenue growth accelerated sharply and the company raised guidance. Investors rewarded the better-than-anticipated topline, improving margins, and expanding strategic AI partnerships.

Key takeaways

Q2 revenue reached $443 million, growing 44% year over year and 28% excluding M&A contributions.
Adjusted EBITDA rose 56% year over year to $92 million, with margin expansion of 170 basis points to 20.7%.
The company raised the midpoint of its 2026 revenue guidance by $33 million, signaling confidence in ongoing demand.
Growth was driven by adoption of Zeta’s AI-powered platform, including significant acceleration in voice-activated Athena users interacting at 500% higher levels.
Strategic partnerships with OpenAI, Snowflake (100+ shared customers), and Palantir were highlighted as catalysts expanding Zeta’s AI infrastructure presence beyond marketing.

Zevia PBC

ZVIA Q2 2026

Reported: 2026-08-07

Shares of Zevia plunged 15% following earnings as investors reacted negatively to signs of deceleration in execution and a cautious outlook, despite hitting sales guidance. The market penalized the company's acknowledgment of underwhelming in-store execution and the need for urgent improvement in distribution and brand activation.

Key takeaways

Net sales of $45 million landed at the high end of guidance, yet failed to excite investors.
Adjusted EBITDA exceeded expectations by $0.5 million, but this was insufficient to offset concerns.
Management flagged significant shortcomings in go-to-market execution, especially in-store activation and merchandising.
Strategic priorities focus on expanding singles distribution, improving in-store productivity, and sharpening brand targeting—initiatives viewed as corrective rather than growth drivers.
CEO emphasized a cautious tone, outlining a “listening tour” and the need for urgent operational improvements, signaling a tempered outlook and potential near-term challenges.

Community

See what investors are trading, holding, and sharing

🌐

📈

📊

🏦

🪙

💱

#	Asset	Price	Community %	Type	Currency	Sector

2026 © AllInvestView

Twitter YouTube Reddit Feature Requests Changelog Support Pricing Help

Support email: [email protected]

Terms of Service | Privacy Policy

Free Trackers · Dividend Apps · Tax Reporting · UK · Australia · Germany · Guides · Ticker Logos

Stock Directory · Financial Glossary · Portfolio Templates · Top Dividend Stocks · Investing in US · Investing in UK · Import Guides · Stock Comparison · Earnings Recaps

Data disclaimer: AIV (AllInvestView) assumes no liability for the information presented. Users are encouraged to exercise caution and carefully consider the accuracy, completeness, and relevance of the information provided.

It's important to remember that our website should complement your independent market research rather than replace it. The past performance of assets should not be regarded as a guarantee of future results. AllInvestView is not a registered investment advisor or broker/dealer, and the information presented here is for educational and informational purposes only. We value your trust and are committed to providing you with valuable market insights while emphasizing the importance of responsible decision-making in your investment journey.